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The respiratory system of horses is the major limiting factor for athletic performance. As 
such, any respiratory impairment can have a considerable effect on athletic performance. A 
common site for this impairment to occur is the upper respiratory tract with laryngeal 
collapse being the most common form in horses. The recurrent laryngeal nerves in the 
horse are the longest nerves in the body and prone to degenerative axonopathy. This is 
termed recurrent laryngeal neuropathy (RLN) and results in neurogenic atrophy of the 
cricoarytenoideus dorsalis (CAD) muscle. Loss of function of the CAD leads to dynamic 
laryngeal collapse when exposed to the negative airway pressures produced during 
exercise. As a result, RLN is a common cause of reduced athletic performance in horses. 
Currently the most commonly performed treatment for RLN in horses is a static prosthetic 
laryngoplasty. This procedure has a relatively poor success rate in performance horses 
(ranging from 50-70%) and high complication rate of between 26-43%.1-4 Two of the 
major complications are dysphagia and loss of abduction. In general, many of the 
complications can be attributed to either under or over abduction of the arytenoid and static 
laryngoplastic fixation.  
The objective of the research reported here was to develop a laryngoplasty system that 
allowed for alteration of the degree of arytenoid abduction post-operatively. This thesis 
outlines the successful development of such a device.  
Initially, the existing standard laryngoplasty procedure was examined mechanically and a 
variety of prototypes were developed and evaluated. Subsequently, we selected the final 
dynamic laryngoplasty system (DLPS) for further evaluation. After optimising the position 
of attachment to the arytenoid using an anchor, the prototype device was mechanically 
tested under static loading, cyclic and ramp (single linear loading) to failure conditions. 
This study found the device was able to cause effective shortening of a suture loop with 
	 5	
minimal cyclical loss and was able to resist ramp testing sufficiently to justify further 
evaluation. Additional in vitro testing was performed using cadaveric larynges and 
demonstrated that the DLPS was able to cause effective increases in arytenoid abduction 
within the confines of equine laryngeal anatomy. The final in vitro study tested the ability 
of the DLPS to achieve and maintain arytenoid abduction during testing using a static 
airflow model with a flow rate of 55L/sec which was consistent with previously published 
research. After completion of the in vitro studies an in vivo proof of concept study was 
performed. This demonstrated that the device could be effectively delivered via a standing 
procedure under sedation and allowed for selective alteration in arytenoid abduction at 7 
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Chapter 1: Introduction, literature review and project aims 1 
 2 
1.1 Introduction  3 
The major limiting factor in a horses’ exercising capacity is the respiratory system.5 Within 4 
this system the upper airway is a common site of obstruction to airflow that can result in 5 
poor performance. The importance of the respiratory system in horses is illustrated by the 6 
massive increase in airflow associated with exercise. At rest horses have a tidal volume of 7 
approximately 5 L and breathing rate of 15 breaths per minute leading to a minute 8 
ventilation of 75 L per minute. With exercise this  increases by between 20-60 times to 9 
1200-2580 L per minute.6-10 These massive airflow rates lead to large negative airway 10 
pressures affecting the upper airway.6,11 Peak negative airway pressure during inhalation 11 
has been reported to range from 3922 to 4903 Pa whilst galloping at 14m/sec on a 12 
treadmill with a peak inspiratory flow rate of 2580L/min.9,12 Humans in comparison have a 13 
negative pressure of only 441 Pa during a forceful sniff with a flow rate of 1.1L/sec.12,13   14 
Horses are obligate nasal breathers. This means they are unable to breathe through the oral 15 
cavity and all air has to pass through the nares. As a result, horses must accommodate the 16 
massive increases in airflow of exercise solely through the nasal cavity. During inspiration 17 
90% of the resistance to airflow is attributed to the upper airway and this is evenly 18 
distributed between the nares and the larynx.6,12 The nares are rarely a cause of clinically 19 
relevant increases in airway resistance in horses. However, in contrast, the larynx is an 20 
important site of increased airflow resistance even in a normal functioning state. When the 21 
larynx is dysfunctional it can cause a massive negative effect on airflow and performance 22 
as a result.  23 
The larynx is short tube that connects the pharynx to the trachea.14 It is an anatomical 24 
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structure that is uniquely required to serve two major functions: facilitating airflow during 25 
breathing; and preventing water and food from entering the trachea during deglutition. To 26 
achieve its required functions the larynx needs to be able to close fully during swallowing 27 
and then open maximally during exercise. Abduction of the arytenoid cartilages results in 28 
enlargement of the rima glottidis and is controlled in the horse by a single pair of muscles 29 
called the cricoarytenoideus dorsalis (CAD). These muscles, one on each side of the 30 
larynx, are solely responsible for opening each hemi-larynx to a point that they minimally 31 
obstruct airflow. These muscles are innervated by the left and recurrent laryngeal nerves 32 
which are branches of the vagus. The left recurrent laryngeal nerve is the longest nerve in 33 
the horse’s body measuring up to 250 cm in length, twice as long as other motor nerves in 34 
the horse and approximately 31 cm longer than the right side.15 The greater length on the 35 
left is due to the nerve coursing around the aortic arch, compared with the right which does 36 
not. As a result of this unique anatomy the left recurrent laryngeal nerve has historically 37 
been thought to be most susceptible to degeneration. However, the role of nerve length in 38 
the pathogenesis of this degeneration is uncertain at this stage.16 Degeneration of the 39 
recurrent laryngeal nerve is commonly termed recurrent laryngeal neuropathy (RLN). This 40 
nerve dysfunction then leads to CAD muscle atrophy and hence an inability to sufficiently 41 
abduct the affected left arytenoid cartilage.17-20 When complete, this has been termed 42 
laryngeal hemiplegia (LH). This reduction in the ability to open the larynx causes 43 
increased resistance to airflow and results in reduced oxygen delivery leading to reduced 44 
athletic performance. 21,22  45 
Recurrent laryngeal neuropathy, resulting in laryngeal collapse has been recognised as a 46 
performance-limiting disease process in horses since the 1800s.23 The neuropathy is likely 47 
to have a genetic basis however the precise aetiology remains uncertain.18,24-26 It is caused 48 
by a progressive distal axonopathy and has historically been thought to affect multiple 49 
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nerves in the body but with the left recurrent laryngeal nerve most severely affected. 50 
However, recent histological evaluation of the recurrent laryngeal nerve and other nerves 51 
has determined the degeneration to be more correctly termed a bilateral mononeuropathy 52 
with the degeneration limited to the recurrent laryngeal nerve.27 The prevalence of RLN 53 
varies between breeds with larger breeds more commonly affected.28,29 In Thoroughbreds 54 
the prevalence of RLN has been reported based on resting endoscopic findings to be 55 
between 2.6-8%.30 In heavy draught horse breeds a prevalence of up to 35% has been 56 
reported.31  57 
 58 
1.2 Equine Laryngeal Anatomy  59 
The larynx in the horse consists of three single cartilages (cricoid, thyroid and epiglottic) 60 
and the paired arytenoid cartilages (Figure 1). 14,32  61 
 62 
Figure 1. Single cricoid, thyroid, and epiglottic cartilages and paired arytenoid cartilages 63 
form a communicating channel between the pharynx and trachea. Adapted from Janicek et 64 
al. 2008. 65 
 66 
	 14	
The cricoid and thyroid cartilage are both composed of hyaline cartilage with the epiglottis 67 
being elastic cartilage. The arytenoids are a combination of cartilage types with the 68 
muscular process being hyaline with the remainder being elastic. The cricoid cartilage is 69 
signet ring shaped and articulates with the thyroid at the cricothyroid articulation. It also 70 
articulates with each of the arytenoids at the cricoarytenoid joint which is a diarthrodial 71 
saddle-shaped joint. This joint is located such that the arytenoids are situated on either side 72 
and in front of the cricoid and partly medial to the thyroid cartilage. The arytenoids are 73 
slightly pyramidal in form and have three processes: the muscular, the vocal and the 74 
corniculate process.14 The cricoid cartilage has been found on computed tomographic 75 
imaging to have notable conformational differences at the caudal edge in Thoroughbred 76 
larynges.33 These differences are also markedly evident during dissections of the equine 77 
larynx. The CAD muscle is a strong fan shaped muscle that attaches to the apex of the 78 
muscular process of the arytenoid. A cartilaginous ridge extends cranially from the apex of 79 
the muscular process along a line parallel to the orientation of the CAD muscle and is 80 
termed the arcuate crest (crista arcuata). The paired left and right CAD cover the dorsal 81 
surface of the cricoid and each has two neuromuscular components.34 Each muscle 82 
originates from half of the caudal cricoid lamina including the median ridge and the fibres 83 
converge into a tendon that inserts onto the muscular process of the arytenoid.14 The action 84 
of the CAD muscle is to dilate the rima glottidis by rotating the arytenoid at the 85 
cricoarytenoid joint into an abducted position. The recurrent laryngeal nerve innervates the 86 
CAD muscle and this is the only abductor of the larynx. The recurrent laryngeal nerve also 87 
innervates the cricoarytenoideus lateralis (CAL), the arytenoideus transversus and the 88 
thyroarytenoideus muscle group (combined ventricularis and the vocalis muscles) (Figure 89 
2).14,16 All of these muscles are associated with adduction of the larynx and are similarly 90 
affected to the CAD when there is RLN.35  91 
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 92 
Figure 2. Overlay of intrinsic laryngeal muscles that abduct and adduct the diameter of the 93 
rima glottidis via contraction. Adapted from Janicek et al. 2008. 94 
 95 
1.3 Respiratory physiology related to laryngeal dysfunction 96 
The respiratory system is the limiting factor for athletic performance in horses. 6,36,37 This 97 
is due to the delivery of oxygen being the primary limiting factor to increases in VO2max 98 
during strenuous exercise.38 The equine cardiovascular and muscular systems can transport 99 
and utilise more oxygen than the lungs can supply.36 As a result during strenuous exercise 100 
normal horses develop hypoxaemia (<60 mmHg) that will negatively impact further 101 
aerobic performance.38 Any impairment of the equine respiratory system such as laryngeal 102 
collapse caused by RLN, will compromise athletic performance. This has been 103 
demonstrated clearly in exercising horses where transection of the recurrent laryngeal 104 
nerve significantly increased respiratory impedance and worsened exercise-induced 105 
hypoxemia. 10,19 Horses with RLN cannot achieve maximal abduction of the affected 106 
arytenoid cartilage, and as negative inspiratory pressure increases with exercise, leads to 107 
progressive narrowing of the rima glottidis due to arytenoid collapse. This subsequently 108 
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leads to hypoxemia, hypercarbia and metabolic acidosis occurring more quickly in horses 109 
affected with RLN compared to non-affected horses and results in musculoskeletal fatigue 110 
and poor performance.22,39 However, research has shown that the currently performed LP 111 
improves airflow and reduces inspiratory resistance but does not restore airway mechanics 112 
or arterial blood gases to normal limits.10,19,22,40 Furthermore, one study found that the 113 
performed LP diminished normal laryngeal protective mechanisms leading to airway 114 
contamination.10 115 
 116 
1.4 Aetiology and pathophysiology of RLN 117 
Laryngeal dysfunction is a common equine clinical problem and a genetic basis is most 118 
likely, however, in a majority of affected horses the precise aetiology is uncertain.41 As a 119 
result, between 89-94% of cases of laryngeal hemiplegia of unknown aetiology are 120 
attributed to idiopathic RLN.26,42 The cause of RLN been hypothesised to range from 121 
mechanical stretching of the recurrent laryngeal nerve during neck movement, growth and 122 
caudal movement of the heart during embryogenesis to environmental factors, including 123 
toxins.16 Histologically, idiopathic RLN is characterised by distal degeneration of the 124 
recurrent laryngeal nerve.27,35,43 However, other disorders can cause damage to the 125 
recurrent laryngeal nerve and this has been previously reported to be the case for the 126 
remaining 6-11% of horses presented with LH. 26,42 These include guttural pouch mycosis, 127 
perivascular injections of irritant drugs in the area of the recurrent laryngeal nerve, neck 128 
trauma and neoplasia.26 Of horses with a specifically identified cause of RLN more than 129 
half of these cases were bilaterally affected. 26,42 Regardless of the exact aetiology, the 130 
result is neurogenic atrophy of the laryngeal musculature, which mechanically results in an 131 
inability to effectively abduct the affected arytenoid. 132 
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 133 
1.5 Diagnosis of RLN 134 
Recurrent laryngeal neuropathy results in neurogenic atrophy of the CAD and leads to an 135 
inability to abduct the affected arytenoid effectively from the airway. The diagnosis of 136 
RLN can be suspected on the basis of history and physical examination.44 However, as 137 
previously discussed, RLN and the subsequent CAD atrophy varies in severity. As a result, 138 
there are differing effects on performance depending on the degree of airway obstruction 139 
and the nature of the intended athletic function of the horse. This results in the disorder 140 
having a range of effects on performance from career limiting to clinically insignificant 141 
inspiratory noise. As such, advanced diagnostic measures have been developed to 142 
accurately diagnose and classify all affected horses in an effort to target treatments more 143 
effectively. Diagnostic tools that have been investigated in the evaluation of RLN in horses 144 
include: standing endoscopy, dynamic endoscopy, laryngeal ultrasound, exercise 145 
spirometry, sound analysis, electromyography, CT and MRI.19,45-50 The current gold 146 
standard for diagnosis of RLN is considered to be an exercising (dynamic) endoscopic 147 
examination, which may be performed either on a high-speed treadmill or “over ground”.5 148 
The video-endoscopic images are recorded and can be played back frame by frame to 149 
allow for accurate diagnosis and classification of the type and severity of upper airway 150 
dysfunction present in any horse suspected to be suffering from RLN.47,51-53  151 
Several grading systems have been developed for standing endoscopic assessment of 152 
laryngeal function.54,55 These grading systems categorise horses based on arytenoid 153 
abduction function at rest in an effort to grade the severity of dysfunction and draw 154 
parallels relating to the likely corresponding function during exercise. As a result, standing 155 
endoscopic grading was developed to allow for consistency in reporting of this condition 156 
and also to allow evaluation of treatment success. A seven-grade system has been 157 
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developed and is widely accepted for use during standing endoscopic examinations as 158 
proposed initially by the Havemeyer workshop group and international experts in 2003 159 
(table 1).55  160 
Grade  Description Sub-grade 
1 All arytenoid cartilage 
movements are synchronous and 
symmetrical and full arytenoid 
cartilage abduction can be 
achieved and maintained.  
 
2 Arytenoid cartilage movements 
are asynchronous and/or larynx is 
asymmetric at times but full 
arytenoid cartilage abduction can 
be achieved and maintained.  
2.1 Transient asynchrony, flutter, or delayed 
movements are seen. 2.2 There is asymmetry of the 
rima glottidis much of the time due to reduced 
mobility of the affected arytenoid and vocal fold but 
there are occasions, typically after swallowing or 
nasal occlusion when full symmetrical abduction is 
achieved and maintained.  
3 Arytenoid cartilage movements 
are asynchronous and/or 
asymmetric. Full arytenoid 
cartilage abduction cannot be 
achieved and maintained.  
3.1 There is asymmetry of the rima glottidis much of 
the time due to reduced mobility of the arytenoid and 
vocal fold but there are occasions, typically after 
swallowing or nasal occlusion, when full symmetrical 
abduction is achieved but not maintained.  
3.2 Obvious arytenoid abductor deficit and arytenoid 
asymmetry. Full abduction is never achieved. 3.3 
Marked but not total arytenoid abductor deficit and 
asymmetry with little arytenoid movement. Full 
abduction is never achieved  
4 Complete immobility of the 




Table 1. Havemeyer grading system of laryngeal function in the standing unsedated horse. 161 
This grading generally refers to the left arytenoid cartilage in reference to the right but can 162 
be applied to right sided dysfunction.  163 
  164 
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In Australia and New Zealand a five-grade scale (table 2) has been used historically but is 165 
gradually being replaced with the aforementioned Havemeyer scale.54  166 
Grade Description  
1 All movements, both adduction and abduction are synchronised and 
symmetrical. 
2 All major movements are symmetrical and a full range is achieved. 
Transient asynchrony, flutter or delayed opening may be seen.  
3 Asymmetry of the rima glottidis at rest due to reduced motility by the left 
arytenoid cartilage and vocal fold. On occasions, typically after swallowing 
or during the nostril closure manoeuvre, full symmetrical abduction is 
achieved. 
4 There is consistent asymmetry of the rima glottidis but with some residual 
active motility by the left arytenoid cartilage and vocal fold. Full abduction 
is not achieved at any stage.  
5 True hemiplegia. There is obvious and consistent asymmetry of the rima 
glottidis with no residual active motility by the left arytenoid cartilage and 
vocal fold.  
Table 2. Five-point grading system as per Lane 2004. 167 
 168 
The use of these resting endoscopic grading systems have been shown to be subjective and 169 
influenced by factors such as sedation, which nostril the examination is performed via and 170 
the day of the examination.56Further studies have shown that the correlation between 171 
resting grades and dynamic laryngeal collapse is not highly reliable.47,52,57,58 Laryngeal 172 
ultrasound has been shown to have a higher sensitivity and specificity (90% and 98% 173 
respectively) than resting upper airway endoscopy (80 and 81% respectively) in the 174 
prediction of abnormal arytenoid movement determined during a treadmill upper airway 175 
endoscopic examination.59 176 
As a result of the inaccuracy of using standing laryngeal grade as a predictor of laryngeal 177 
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collapse methods of performing dynamic examination of the upper respiratory tract have 178 
been developed and are considered the gold standard diagnostic technique. These 179 
examinations are commonly performed using a high-speed treadmill or more recently 180 
using an over ground endoscopy system. A grading system to use during these dynamically 181 
exercising examinations has been proposed by Rakestraw (table 3).60 This system 182 
differentiates based on the degree of arytenoid collapse at exercise. 183 
Grade Description 
A Full abduction of the arytenoid during inspiration  
B Partial abduction of the affected arytenoid cartilage (between resting position and full 
abduction)  
C Abduction less than resting position, including collapse into the contralateral half of 
the rima glottidis during inspiration  
Table 3. Grading system of laryngeal function as assessed during exercise. This grading 184 
generally refers to the left arytenoid cartilage in reference to the right but can be applied to 185 
right sided dysfunction.  186 
 187 
1.6 Treatment options for RLN 188 
Several treatment options are available for horses with RLN and which option is selected is 189 
often based on the nature of the presenting complaint, the age of, and the intended future 190 
use of the horse. For horses required to perform at maximal levels of performance such as 191 
racehorses, the surgical treatments available include a prosthetic laryngoplasty, 192 
ventriculectomy, ventriculocordectomy, re-innervation of the CAD muscle and partial 193 
arytenoidectomy. The most commonly selected procedure in horses that are required to 194 
work and race at maximal exercise capacity for distances greater than 800m is a prosthetic 195 
laryngoplasty.61 This is commonly combined with either a ventriculectomy or a 196 
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ventriculocordectomy which may be performed unilaterally or bilaterally to abolish vocal 197 
fold collapse and reduce respiratory noise.1,4,62,63 Where noise is the predominant 198 
complaint, such as in performance horses, then a ventriculectomy or a 199 
ventriculocordectomy alone can be effective in reducing respiratory noise.40,62,63 200 
Neuromuscular pedicle grafts can be used to re-innervate the CAD muscle and are suitable 201 
for any affected horse but used most commonly in young horses with grade 3 laryngeal 202 
movement, where return to athletic function is not expected within 4 months of surgery.20 203 
Successful re-innervation of the CAD following neuromuscular pedicle grafts can take 6-204 
12 months and is not, as a result, always suitable for horses that are required to return to 205 
athletic performance quickly. A partial arytenoidectomy is often used as the treatment 206 
option for failed laryngoplasty surgeries or in cases of arytenoid chondritis causing 207 
malformation of the arytenoid cartilage. This has been found to improve airflow dynamics 208 
compared to an induced laryngeal hemiplegic state but not back to normal values and not 209 
as significantly as a laryngoplasty.10 210 
 211 
1.7 Current Laryngoplasty Techniques, Success Rates and Complications 212 
1.7.1 Laryngoplasty technique 213 
Treatment by laryngoplasty was first reported by Cadiot in 1893, who transcutaneously 214 
sutured the paralysed arytenoid to the thyroid cartilage.64 With remarkably little variation, 215 
the technique described by Marks and colleagues in 1970 is still accepted as the treatment 216 
of choice, despite the limited success and host of possible complications.65 This technique 217 
fundamentally places a prosthesis to replace the function of the atrophied CAD muscle. 218 
Generally speaking, a suture material is placed from the cricoid to the muscular process of 219 
the arytenoid and then tightened to achieve the desired degree of arytenoid abduction. The 220 
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arytenoid is then fixed in a static position.  221 
 222 
1.7.2 Success Rates  223 
The reported success rate of the modern laryngoplasty procedure is extremely varied and 224 
ranges from 5% to 95%.1,2,66-68 Of interest, there has not been a marked improvement in 225 
reported success rates over time.1,61,66,69,70 The remarkable variation in reported success 226 
rates is due to the different criteria used to measure success and the intended use of the 227 
horse. Thoroughbred racehorses have a lower success rate (48-66%) compared to breeds 228 
not intended for racing (90-95%).1,2,67,69 Laryngoplasty in horses not intended to race, or to 229 
race over short distances (<800m) will be more successful due to the lower intensity of 230 
performance or reduced reliance on aerobic metabolism respectively required post-231 
surgery.61 232 
The current prosthetic laryngoplasty is a commonly performed procedure that has 233 
significant scope for improvement. Clearly, the success rate is strongly dependent on the 234 
intended use of the horse but for maximal athletic performance the success rates are 235 
relatively poor.1,2,61,67,70 Because of this scope for improvement an enormous number of 236 
variations on the basic theme of a static laryngoplasty have been developed and 237 
subsequently researched with none of them being uniformly embraced by the equine 238 
surgical community.4,71-75 239 
 240 
1.7.3 Complications 241 
Due to the static nature of the laryngoplasty procedure, the horse’s larynx is permanently 242 
affixed in a partially abducted position post-operatively. This position is a compromise 243 
between the requirements of the larynx to be abducted for maximal airflow yet still being 244 
able to function in preventing food contamination of the airway. The complications 245 
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associated with the laryngoplasty procedure are mostly caused as a result of this 246 
compromise. Many of these complications can be related to either over or under abduction 247 
of the statically abducted arytenoid.  248 
A variety of complications have been attributed to over abduction and dysphagia as a result 249 
although this is not always a direct linear relationship.61,68 Post-operatively, 9-16% of 250 
horses that underwent a laryngoplasty procedure have been reported to have some degree 251 
of nasal discharge in the immediate postoperative period.1,3 Coughing has been reported to 252 
occur in 13% of draft breeds, in 18-33% of mixed breeds, and in 26-43% of racehorses 253 
undergoing laryngoplasty.1,2,4,66,76,77 In some cases, coughing may solely be a manifestation 254 
of over abduction of the arytenoid.78 Given that the most common cause for post-operative 255 
coughing is aspiration of feed material, most management procedures are aimed at 256 
reducing this complication by reducing aspiration. Although marked dysphagia was 257 
associated exclusively with high amounts of abduction in one article, other investigators do 258 
not believe this association has a direct linear correlation.61,68 Rates of intraoperative target 259 
abduction vary depending on the study and have been reported to be 50-90%.4,56,68 260 
Furthermore, one study reported that abduction above resting position did not improve 261 
performance but increased the rate of complications.2 It is commonly accepted that 262 
laryngoplasty procedures result in airway contamination over normal or hemiplegic 263 
states.10 When excessive abduction is observed post-operatively and combined with 264 
significant coughing and dysphagia, a second surgery to remove, replace, or loosen the 265 
prosthesis is often recommended. 266 
Complications due to loss of, or under, abduction are mostly related to poor exercise 267 
performance. In general, loss of abduction is a well-recognized phenomenon of the 268 
currently performed static laryngoplasty procedure and occurs most commonly in the first 269 
7 days.66,68 Although greater abduction has been associated with higher rates of 270 
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complications, it has also been associated with a greater likelihood to return to work and 271 
improved performance.2,77 As a result, the optimal degree of abduction is difficult to 272 
evaluate at the time of surgery and even more difficult to maintain post-operatively. 273 
Furthermore the “ideal” degree of abduction is likely highly variable and will likely need 274 
to be determined on a case-by-case basis. For example, for horses performing at 275 
submaximal levels (e.g., jumpers, draft horses), the concern is more often with reduction in 276 
noise and not necessarily maximal airflow. Hence, a laryngoplasty at a lower percentage of 277 
maximal abduction may be sufficient for their purpose and may not have as many 278 
postoperative complications. In contrast, racehorses require maximal airway dilation to 279 
allow them to compete and, as a result, may require more aggressively abducted 280 
laryngoplasty procedures but with a static procedure these will inevitably be associated 281 
with much higher rates and severities of complications. Satisfactory abduction at 9 days 282 
postoperatively was achieved in only 77% of horses undergoing laryngoplasty surgery, 283 
with failures mostly attributable to suture cutting through the laryngeal cartilages.66 These 284 
failures occurred in two 2-year-olds and a 3-year-old, leading the authors to hypothesise 285 
that the cartilage of young horses was weaker and more prone to failure compared with 286 
older horses.61 This claim was refuted, however, in an in vitro study determining pull-287 
through forces that indicated no difference related to age.79 Furthermore, the density of the 288 
cricoid cartilage has been found to be unrelated to age, suggesting that laryngoplasty 289 
failure is independent of this factor.79 Of 200 laryngoplasty surgeries performed in one 290 
study, 5% had repeated surgery to tighten or replace prostheses within 7 days 291 
postoperatively.68 In addition to this short-term loss of abduction, longer-term loss of 292 
abduction is also a commonly reported. It is often extremely difficult to determine the 293 
exact reason for this failure. Complications such as prosthesis or cartilage failure are two 294 
commonly postulated reasons. Attempting efforts to determine the reason for these long-295 
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term failures. Suggested factors include acute mechanical cartilage failure, cyclic cartilage 296 
failure resulting in gradual prosthesis loosening, improper prosthesis placement resulting in 297 
biomechanical disadvantage and any disease state rendering cartilage weaker than 298 
normal.77 Efforts to reduce acute mechanical pull-out using novel prosthesis systems have 299 
been performed but have not gained widespread acceptance.75,80 Recurrent laryngeal 300 
neurectomy to abolish any residual adductor muscle activity that may contribute to 301 
continued cyclic forces acting on the prosthesis was not effective in improving 302 
postoperative racing performance.77 Improper placement of the prosthesis overly lateral on 303 
the cricoid results in loss of mechanical advantage and can lead to decreased abduction.33  304 
 305 
Horses that have undergone a laryngoplasty have been shown to be at an increased risk of 306 
suffering from exercise induced pulmonary haemorrhage post-operatively.81  307 
Laryngoplasty failure due to persistence of an abnormal respiratory noise or poor 308 
performance can be due to laryngoplasty failure in general or due to the development of 309 
other forms of dynamic laryngeal collapse such as dorsal displacement of the soft palate.82 310 
 311 
 312 
1.8 Biomechanics of Laryngoplasty  313 
The current traditional prosthetic laryngoplasty utilises a prosthetic material to replace the 314 
compromised CAD muscle function of the larynx and so achieve arytenoid abduction, 315 
allowing for effective airflow. However, whilst the basic premise of the laryngoplasty has 316 
not changed, the surgical techniques currently employed to achieve this are extremely 317 
varied (e.g. suture type, suture numbers, position) and have been associated with unreliable 318 
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results. These static surgical options focus on the abduction of the arytenoid to a 319 
predetermined position and maintaining it in that position.  320 
There are four central components to the laryngoplasty construct. These are; the arytenoid 321 
cartilage, 2) the cricoid cartilage, 3) the cricoarytenoid articulation and 4) a prosthetic 322 
suture/material. How these segments interact determines the effectiveness of obtaining and 323 
maintaining effective arytenoid abduction. Recent research has focused on the interplay of 324 
these central components and attempted to maximise the stability of the surgical construct. 325 
Mechanical research of the laryngoplasty has historically focused on single cycle testing to 326 
failure.79,80,83-85 Recently, cyclical models of laryngoplasty testing have been reported and 327 
are likely a more critical evaluation of traditional and novel laryngoplasty techniques as 328 
they test smaller repeated forces on the construct which is more comparable to the stresses 329 
on the construct during breathing, coughing and swallowing.75,86  330 
The load applied to the cartilage-suture construct in vivo is an important factor required for 331 
effective mechanical evaluation of a laryngoplasty construct. An in vivo study evaluated 332 
the force required to achieve optimal arytenoid abduction, which was found to be 333 
27.6±7.5N. During swallowing and coughing, the mean force on the suture increased by 334 
19.0±5.6N and 12.1±3.6N, respectively.87,88 Additionally, these horses were instrumented 335 
for 24hrs and it was found that the suture underwent cyclical loading due to swallowing at 336 
a mean of 1152 times in that period, a rate of 0.8 times per minute. From this research, it 337 
was estimated that the peak force on a laryngoplasty construct would be 46.6N. This 338 
reported force to obtain abduction was much higher than the force reported to cause 339 
maximal abduction in a previous study that was only 14.7N.89 However, this was an in 340 
vitro study on cadaveric larynges and the load may have been lower than in vivo due to the 341 
absence of muscular function or different suture placement positioning. 342 
 343 
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1.8.1 The arytenoid cartilage 344 
The arytenoid cartilage has historically been suspected to be a major source of abduction 345 
loss. This suspicion has led to significant research focused on the muscular process and its 346 
role in maintaining abduction.79,83-85 This has included evaluation of the effect of age, 347 
placement site, implantation technique and various suture configurations.79,84,85,90 Most of 348 
this research has been performed in single cycle to failure models and has uniformly been 349 
associated with loads at failure that are much higher than those demonstrated to occur in 350 
vivo. In one study, six different suture configurations in the muscular process of the 351 
arytenoid were examined using mechanical testing.85 It was concluded that sutures that 352 
sufficiently engaged the spine of the muscular process alone or in conjunction with a 353 
second suture were the most biomechanically stable. These results parallel research in dogs 354 
that found the size of the hole for the suture or the suture size had no or little effect, but 355 
that sutures incorporating the arcuate crest were biomechanically superior, overall.83 356 
Recently, transection of the CAD muscle immediately behind its insertion onto the 357 
muscular process has been reported to allow access to debride the cricoarytenoid (CA) 358 
joint.74 Transection of the CAD at its insertion also allows for superior identification of the 359 
muscular process and possibly for more accurate and consistent suture placement as a 360 
result.  361 
The method of suture placement into the arytenoid cartilage has historically not been 362 
shown to be an important factor (e.g. tunnelling a hole with a hypodermic needle compared 363 
to a swaged on needle).84 However, the use of a conventional cutting needle compared to a 364 
tapercut needle resulted in significantly lower peak loads at failure in a single cycle model 365 
and resulted in significantly more distraction in a cyclical model.93 This was thought to 366 
result from the cutting needle creating a groove into which the suture propagated more 367 
readily than when placed with the tapercut needle. Recently, a screw placed into the 368 
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arytenoid has been utilised as a point of anchorage in the arytenoid.71 This technique has 369 
not been utilised widely, however it is thought to increase stability of the arytenoid 370 
segment of the laryngoplasty construct. The use of such a suture anchor has been 371 
demonstrated to reduce the load required to achieve effective arytenoid abduction by 372 
approximately 50%.91 Regardless of the method of attachment to the arytenoid, based on 373 
the cyclical testing that has been performed it appears that the arytenoid cartilage is 374 
unlikely to be a major source of loss of abduction if appropriate attachment is achieved.92  375 
 376 
1.8.2 The cricoid cartilage 377 
More recently, the cricoid cartilage has been identified as an important component that 378 
may be a source of variability and potential laryngoplasty failure. Computed tomographic 379 
imaging of the cricoid has found there to be notable conformational differences among 380 
cricoid specimens from a group of Thoroughbred larynges.33 Logically, this variability at 381 
the caudal aspect of the cricoid cartilage may result in some variability in the ability of the 382 
cricoid to maintain a suture in the laryngoplasty construct. Suture migration in the cricoid 383 
was identified as the cause of 50% of short term excessive loss of abduction in when it 384 
occurred in a series of 200 horses.68  385 
Various techniques associated with the cricoid cartilage have been proposed to reduce the 386 
loss of abduction. These range from sawing the suture to ‘seat it’ prior to tying, placing the 387 
sutures ‘into’ the dorsal notch when present, double loops around the caudal edge of the 388 
cricoid and novel laryngoplasty systems involving cables and washers or anchors.75,80  389 
 390 
1.8.3 The cricoarytenoid articulation 391 
The cricoarytenoid articulation (CA) is an important component of a laryngoplasty 392 
construct. The distances from the longer corniculate process to the articulation and 393 
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subsequently to the shorter muscular process are important components of a lever arm. As 394 
a result of this lever arm, small changes in the position of the muscular process will result 395 
in proportionally much larger changes in the positioning of the corniculate process. For 396 
example, a loss of 5mm between the arytenoid/suture/cricoid construct will lead to a 15-397 
20mm loss at the corniculate process and resultantly significant abduction loss.93  398 
Recently the effect of stabilising the CA by injecting polymethylmethacrylate into the joint 399 
space was evaluated using a static airflow model. 93 It was found that stabilising the joint 400 
with PMMA resisted collapse of the airway and reduced the force experienced by the 401 
suture during maximal abduction. More recently, a surgical technique to promote ankylosis 402 
of the CA has been published that resulted in decreased loss of abduction of the arytenoid 403 
in the post-operative period.74 Utilisation of a technique to ankylose the CA joint reduced 404 
the forces on the laryngoplasty sutures and resulted in less loss of abduction post-405 
operatively and should be considered as a means to help reduce loss of arytenoid 406 
abduction.74,93,94 407 
 408 
1.8.4 The prosthetic suture/material 409 
Various prosthetic materials have been reported to successfully perform a laryngoplasty. 410 
Materials reported are not limited to but range from catgut, wire, nylon, polyester, 411 
polytetrafluoroethylene, ultra-high molecular weight polyethylene, to braided cable.66-412 
68,73,75,77,78,88,95,96 Many of these materials are much stronger than the necessary 413 
requirements to obtain and maintain abduction. It is broadly accepted that a non-absorbable 414 
material that is of sufficient size (e.g. #5 [7.0metric]) is very unlikely to itself fail 415 
mechanically and cause of loss of abduction in an equine laryngoplasty construct. The 416 
strength of these materials is so far greater than the loading seen in a laryngoplasty 417 
construct in vivo that so long as a reasonable suture material is selected it will not be a 418 
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cause of laryngoplasty failure.97 It has been found that the use of two sutures in the 419 
construct is superior to a single strand.85 This is likely due to increased cartilage stability 420 
with two strands rather than any increased strength on the part of the suture. Additionally, 421 
slightly different angles of the sutures have been suggested to increase the CA joint 422 
stability in vitro.98  423 
 424 
 425 
1.9 Conclusions 426 
The currently available laryngoplasty techniques are fundamentally based on achieving a 427 
static partially abducted position of the arytenoid. This permanently abducted position is 428 
inevitably a compromise between the two major functions of the larynx: airflow and 429 
deglutition. As a procedure, it has numerous and varied complications generally associated 430 
with under abduction and reduced airflow or over abduction and contamination of the 431 
airway. These complications are mostly associated with the static nature of the 432 
laryngoplasty. The inability to determine where the “ideal” degree of abduction is at the 433 
time of surgery and the inability, regardless of technique, to reliably position the arytenoid 434 
without loss of abduction are limitations of the current laryngoplasty technique. With these 435 
points in mind the overarching goal of this research was to develop a laryngoplasty 436 
procedure that would be able to modify the degree of abduction of the arytenoid after 437 
surgery. The ability to modify the degree of arytenoid abduction post-operatively may 438 
potentially allow for improved success rates and lower complication rates as a result. As 439 
such, this project attempts to develop such a system for use in horses.  440 
 441 
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1.10 Project Aims and Hypotheses 442 
The principle aim of this project is to develop and evaluate a dynamic laryngoplasty 443 
system (DLPS) for use in horses.  444 
The major hypotheses to be tested are: 445 
1. The developed dynamic laryngoplasty system (DLPS) is able to produce and 446 
maintain a variable degree of arytenoid abduction in vitro 447 
2. In vivo, the DLPS will allow for controlled variation of the arytenoid position 448 
post-operatively  449 
To test these hypotheses the following key objectives were set, each forming major themes 450 
of the project: 451 
 Objective I: Prototype conceptualisation, development and optimisation 452 
a) Prototype conceptualisation and development  453 
b) In vitro comparison of three techniques of prosthesis attachment to the 454 
muscular process of the equine arytenoid cartilage  455 
This objective involved the development of a variety of working concept systems using 3D 456 
printed models. Each system was evaluated for functionality using cadaveric larynges with 457 
modifications and variations made to develop the final DLPS prototype that could be used 458 
to cause controlled alterations in arytenoid abduction. Once the DLPS had been developed 459 
to a working version the suture loop in which the device would be placed was examined in 460 
an effort to maximize the mechanical advantage of its positioning minimising the force 461 
required to achieve arytenoid abduction. This involved comparing 3 methods of attachment 462 
to the arytenoid cartilage and selecting the most mechanically advantageous for use in the 463 
final DLPS system.  464 
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Objective II: In vitro evaluation of the developed DLPS  465 
a) Mechanical testing of a prototype DLPS to cause functional shortening 466 
of a suture loop 467 
b) In vitro evaluation of the efficacy of a prototype DLPS to affect 468 
arytenoid abduction using equine cadaveric larynges 469 
c) Evaluation of a prototype DLPS in vitro using a static airflow model 470 
This objective involved three stages of in vitro testing for the DLPS. The first step was 471 
basic mechanical testing to establish performance under static load, cyclical and ramp 472 
testing situations. Second, the prototype was evaluated using cadaveric larynges to 473 
evaluate the ability to affect arytenoid abduction within the specific anatomy of cadaveric 474 
equine larynges. Finally, the prototype was evaluated using a static airflow model to ensure 475 
the device could maintain the previously demonstrated arytenoid abduction when under 476 
pressures similar to those seen in exercising horses.  477 
 Objective III: Proof of concept study  478 
a) In vivo evaluation of a prototype DLPS in horses 479 
This third and final objective was to confirm the surgical deliverability of the DLPS and 480 
evaluate the degree of surgical arytenoid abduction that could be achieved using the DLPS 481 
at 7-days post-operatively.   482 
  483 
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PART II: PROTOTYPE CONCEPTUALISATION, DEVELOPMENT AND 484 
OPTIMISATION	  485 
	 34	
Chapter 2: Prototype development 486 
 487 
2.1 Introduction 488 
When considering the overarching goal of developing a device that could allow for 489 
alteration in the degree of arytenoid abduction at a point postoperatively, a number of 490 
factors were considered. To achieve this goal a device would need to be “activated” in 491 
some way that would cause an effective change in the degree of abduction of the arytenoid. 492 
When examining the four key components of a traditional laryngoplasty, namely the 493 
cricoid, the arytenoid, the cricoarytenoideus joint and a suture loop, the portion that could 494 
potentially be modified to achieve the above stated goal was considered to be the suture 495 
loop element. The suture loop is a flexible component of the laryngoplasty and if this could 496 
be functionally shortened at a point post-operatively then this would achieve the goal of 497 
selective alteration of arytenoid abduction. The development of a prototype to achieve this 498 
functional shortening is the subject of the remainder of this chapter.  499 
 500 
2.2 Conceptualisation  501 
To achieve the required functional shortening of the suture loop various options were 502 
considered with a focus on developing a simple and robust method. A balloon placed 503 
between the suture loops was considered as means to achieve this shortening. Such a 504 
positioned balloon would cause the suture loop to diverge and shorten as a result, which 505 




Figure 2.2.1 Left view of the larynx with the left CAD muscle removed (top). A stylised 509 
traditionally placed suture loop (middle) from the muscular process of the arytenoid (left) 510 
to the dorsocaudal aspect of the cricoid (right). The conceptualised balloon location 511 
between the suture loop that would result in functional shortening and increased arytenoid 512 
abduction as a result (bottom).   513 
 514 
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However, maintaining the suture loop between the inflating balloon to cause the shortening 515 
was considered to be a problem. To restrain the suture relative to the balloon two parallel 516 
layers of a stiff material that would resist the expansion of the balloon and further direct 517 
this expansion such that it would cause divergence of the previously parallel suture loop 518 
was considered. The original prototype used two discs of plastic either side of a balloon 519 
such that inflation caused the balloon to expand in a controlled fashion (Figure 2.2.2) 520 
 521 
 522 
Figure 2.2.2 The original prototype used two parallel discs of plastic (side view – top left, 523 
top view – top right) that constrained the balloon within the device (end on view non-524 
inflated state – bottom left and end on view inflated state – bottom right).  525 
 526 
The developed device was then placed within the suture loop such that in a non-inflated 527 
state it caused minimal interference with the suture loop but when inflated it caused the 528 
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suture loop to diverge and as a result cause functional shortening. The suture loop, where 529 
in contact with the balloon, had a tube of stiff plastic placed over it to prevent the suture 530 
from sliding past the expanding balloon during inflation. The diameter of the stiff plastic 531 
tube was slightly less than the width between the plastic discs (Figure 2.2.3).  532 
 533 
 534 
Figure 2.2.3 The original prototype demonstrating a suture loop with the stiff plastic tubing 535 
in place over the suture where it is in contact with the balloon.  536 
 537 
This original prototype was effective at causing an increase in arytenoid abduction when 538 
inflated between a suture loop in a cadaveric larynx. However, this original device was 539 
large and cumbersome and additional prototype designs were developed. 540 
 541 
2.3 Prototype versions 542 
Online computer-aided design (CAD) software (www.tinkercad.com) was utilised to create 543 
precision drawings of potential models for evaluation. The models were then printed using 544 
a 3D printer in a variety of different materials, the idea being to develop the original 545 
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concept device outlined above into a refined prototype for further evaluation. In total eight 546 
different design options were developed and printed using 3D printer with three considered 547 
options demonstrated in figure 2.3.1 below. 548 
 549 
 550 
Figure 2.3.1 Three options developed using CAD software and printed using a 3D printer 551 
for evaluation. 552 
 553 
Four types of materials that are available for use in 3D printing were evaluated. These 554 
included nylon, Avrylonitrile Butadiene Styrene (ABS), Polylactic acid (PLA) and 555 
Polymax™ PLA. These materials are thermoplastics that are used in 3D printing and have 556 
been used medical implants. The first three materials were found to be too soft and easily 557 
deformed with little force and as such were not able to constrain the balloon as required to 558 
achieve the required function. The Polymax™ PLA is significantly stiffer than the other 559 
materials but quite brittle such that when the balloon inflated the pillars connecting the two 560 
discs would break (Figure 2.3.2). 561 
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 562 
Figure 2.3.2 A polymax™ PLA 3D printed prototype showing the failure point during 563 
evaluation with a balloon inserted and inflated.  564 
 565 
The 3D printed versions were extremely useful in determining the dimensions of the 566 
device that was most appropriate to fit the anatomic limitations of the equine larynx. A 567 
material that was considerably stronger and stiffer than the 3D printed options was 568 
required. Polyether ether ketone (PEEK) is a colourless organic thermoplastic polymer that 569 
is used in engineering applications and also for non-metallic surgical implants. This 570 
material is commonly engineered to specifications from a block of PEEK in small 571 
prototypes or by liquid mould injection in larger batches. The final version based on 572 
evaluation of the 3D models was selected and engineered from PEEK for further testing. 573 
The selected version using CAD modelling is demonstrated in figure 2.3.3 below.  574 
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 575 
Figure 2.3.3 model selected for manufacturing from PEEK material for in vitro evaluation.  576 
 577 
2.4 Prototype evaluations 578 
The final selected version made from PEEK was tested in a small number of cadaveric 579 
larynges to determine the general function of the device prior to further more stringent 580 
evaluations. The PEEK, unlike the previously evaluated 3D printed materials, did not 581 
deform or break with balloon inflation and resulted in effective increases in arytenoid 582 
abduction when positioned between a suture loop (Figure 2.4.1). 583 
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 584 
Figure 2.4.1 Preliminary evaluation of the PEEK prototypes ability to cause increased 585 
arytenoid abduction with balloon inflation (no inflation – top image and inflated to 29psi 586 
using a pressure syringe – bottom image).  587 
 588 
 589 
2.5 Cadaveric testing of deliverability / functionality 590 
Using an entire equine cadaver, the deliverability and functionality of the developed 591 
prototype was evaluated. Using a standard laryngoplasty surgical approach for access to 592 
the dorsolateral aspect of the larynx the prototype was inserted (Figure 2.5.1).   593 
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 594 
Figure 2.5.1 Surgical approach to the dorsolateral aspect of the larynx demonstrating 595 
effective deliverability of the prototype device in an equine cadaver.  596 
 597 
Subsequently, an endoscope was placed via the right nostril to allow for visualisation of 598 
the rima glottis. Inflation of the balloon component of the prototype resulted in increased 599 
arytenoid abduction (Figure 2.5.2). 600 
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 601 
Figure 2.5.2 Videoendoscopic images of pre-inflation (left) and post-inflation (right) states 602 
using the PEEK prototype selected for further evaluation. 603 
 604 
2.6 Discussion 605 
When considering the goal of developing a device that could allow for alteration in the 606 
degree of arytenoid abduction at a point postoperatively a number of factors were 607 
considered. To achieve this goal a device would need to be “activated” in some way that 608 
would cause an effective change in the degree of abduction of the arytenoid. The suture 609 
loop is a flexible component of the laryngoplasty and if this could be functionally 610 
shortened at a point post-operatively then this would achieve the goal of selective 611 
alteration of arytenoid abduction. With these considerations in mind we developed and 612 
evaluated a variety of prototypes and different methods of attachment to the arytenoid 613 
before the final version of the DLPS was selected for subsequent testing.   614 
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Chapter 3: In vitro comparison of 3 techniques of prosthesis attachment to the 615 
muscular process of the equine arytenoid cartilage 616 
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3.1 Abstract 631 
Objectives- Biomechanical comparison of arytenoid abduction achieved using three 632 
different methods (FASTak II suture anchor and 2 suture patterns) of prosthesis attachment 633 
in vitro to determine which achieves the greatest abduction at various clinically relevant 634 
loads. 635 
Study Design- Experimental. 636 
Study population- Cadaveric larynges from 10 Standardbred racehorses. 637 
Methods- Each larynx was sequentially instrumented with all three options of arytenoid 638 
suture attachment in random order and then underwent mechanical testing at varying loads. 639 
Each construct was abducted at 5 N increments from 0 to 25 N and the left to right quotient 640 
angle ratio (LRQ) measured from digital pictures acquired at each sequential increment.     641 
Results- The FASTak II construct achieved significantly increased arytenoid abduction 642 
(higher LRQ) than both of the suture patterns tested. The largest difference occurred at 5N.  643 
There was no significant difference between the two suture constructs tested at any load 644 
point.  645 
Conclusions- Use of the FASTak II suture anchor resulted in a construct that was 646 
biomechanically superior to the 2 suture patterns tested. This is likely due to the anchor 647 
producing a greater moment of force around the cricoarytenoid joint compared to the 648 
suture patterns. 649 
Clinical Relevance- Use of the FASTak II anchor requires less suture load to achieve 650 
arytenoid abduction in vitro and should occur similarly in vivo. This will reduce the load 651 
on the laryngoplasty construct in general and may result in less abduction loss post-652 
operatively.   653 
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3.2 Introduction 654 
Recurrent laryngeal neuropathy (RLN) is a common problem in horses. The prevalence 655 
varies with breed with rates as high as 10% in Thoroughbreds and 42% in draft horses.26,31 656 
The general principle of the laryngoplasty technique has undergone remarkably little 657 
variation since it was first described by Marks et al. in 1970 and is still considered to be the 658 
treatment of choice for this condition in athletic horses.65 Nevertheless, there is a high 659 
incidence of complications, including complete failure of abduction due to acute construct 660 
failure (3-11%) or gradual loss of abduction, which is reported to occur in nearly all cases 661 
in the longer post-operative period.99-102  662 
Numerous models of single cycle and more recently cyclical testing have attempted to 663 
identify components of the laryngoplasty construct that can be improved in order to 664 
achieve a rigidly stable degree of rima glottis abduction.84,90,92,103-105 Furthermore, multiple 665 
novel prostheses that focus on reducing suture/cartilage failure have been developed and 666 
evaluated since Marks first described the laryngoplasty,.71,73,75,80,96,105 These all have 667 
similar biomechanical fundamentals, being the placement of a prosthesis of some type 668 
from the caudal cricoid to the muscular process tied to cause arytenoid abduction.106 The 669 
orientation and positioning of the prosthetic material at the caudal aspect of the cricoid 670 
cartilage has been examined to evaluate which configuration or positioning achieves the 671 
best biomechanical construct and hence arytenoid abduction.84,98,107,108 Many studies have 672 
focused on different methods of anchoring the respective prosthesis to the muscular 673 
process mostly in single cycle to failure types of testing.79,84,85 One study compared two 674 
techniques for suture placement in the muscular process using single cycle testing and 675 
found no significant differences between direct suture placement using a trocar needle and 676 
through a predrilled hole.11 Another, more recent study by Lechartier et al (2014), 677 
examined the mechanical properties of three different anchoring tests in the muscular 678 
	 48	
process of the arytenoid and found that a single screw technique (Corkscrew® device, 679 
Arthrex) was more stable than a double loop and at least as stable as a single loop of suture 680 
in cyclical testing.25 Additionally, the double loop was found to be the strongest, followed 681 
by the single screw then the single loop in single cycle to failure. It was concluded that the 682 
anchor used was a reasonable option to hold loads in the arytenoid without failure to a 683 
similar level as the more commonly used suture materials.  684 
The focus of the research we report here was to evaluate three different methods of 685 
muscular process attachment in order to determine the most mechanically advantageous 686 
method to achieve arytenoid abduction. We utilised a FASTak II® suture anchor with #2 687 
Fiberwire® preloaded (Arthrex). This anchor is similar to the one used by Lechartier et al 688 
but has a slightly narrower diameter. Specifically, we wanted to determine which of the 689 
three constructs required the least amount of force to achieve clinically relevant arytenoid 690 
abduction.  691 
The aim of this study was to objectively assess the effect of 3 different methods of 692 
arytenoid attachment, 2 suture patterns and one FASTak II anchor, on rima glottis area in 693 
equine cadaveric laryngeal specimens. We hypothesized that the FASTak II anchor would 694 
achieve greater arytenoid abduction than both of the suture patterns evaluated due to a 695 
superior mechanical position on the lever arm (muscular process) of the arytenoid. 696 
Furthermore we hypothesized that the more commonly recommended suture direction of 697 
caudomedial to craniolateral107 would result in a greater arytenoid abduction than a medial 698 




3.3 Materials and methods 702 
3.3.1 Specimen preparation  703 
Larynges from 10 Standardbred horses aged 3-11 years euthanized for reasons other than 704 
respiratory disease were collected and frozen at -200C. Larynges were thawed in batches at 705 
room temperature for 24 hours. The thyroid, cricoid, epiglottic, arytenoid cartilages and the 706 
right cricoarytenoideus muscle were all that were retained for testing. All other soft tissue 707 
including the left cricoarytenoideus dorsalis muscle was removed.  708 
 709 
3.3.2 Specimen positioning 710 
Each larynx was positioned in exactly the same way, in a customized cradle positioned 711 
30cm from a digital camera (HC-V250 high definition digital camera, Panasonic, Osaka, 712 
Japan) that was controlled remotely using generic wireless technology. 84,98,107 A 10cm 713 
ruler was affixed to the cradle in frame as a reference.  714 
 715 
3.3.3 Suture placement 716 
For each larynx, the right side was abducted routinely using suture material and fixed in an 717 
abducted position for the remainder of the testing. Subsequently, the left side of each 718 
larynx was instrumented with each of the three constructs in a random order. Both suture 719 
constructs were placed using #5 Ethibond Excel (7 metric; V-37, Ethicon Inc, NJ)92 in 720 
either a caudomedial to craniolateral or horizontal medial to lateral direction. The 721 
FASTak®II (Arthrex) with preloaded #2 Fiberwire suture (AR-1324HF, Arthrex) was 722 
placed in the arytenoid 10mm cranial to the insertion of the CAD muscle, as described 723 
previously.25 The free ends of the 6 cm long loops were then attached caudally, 724 
immediately adjacent to the cricoid cartilage 1.5cm lateral to the midline, to a hand held 725 
tensiometer (Transducer techniques, Temecula, CA) similar to previous reports.98,107,109 726 
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 727 
3.3.4 Mechanical testing 728 
Each construct was sequentially loaded from 0 to 25N at 5N increments with digital 729 
images acquired at each point. The tested construct was then removed and replaced by the 730 
next construct and repeated until all were tested.  731 
 732 
3.3.5 Left to Right Quotient angle ratio (LRQ) 733 
Arytenoid LRQ was measured and calculated, as described previously, from each 734 
photograph by one observer (B.A) using a soft-ware package (Image J, Bethesda, 735 
USA).51,110 In brief, a line was drawn from the ventral to the dorsal aspect of the rima 736 
glottis and then extended by one third to give a point that was used to measure the left (LO) 737 
and right (RO) arytenoid angles. The LRQ was calculated by LO divided by RO. 738 
 739 
3.3.6 Statistical analysis 740 
Data were checked for normality and homogeneity of variance using D’Agostino’s SK test, 741 
’90, and Levene's, ’60, Robust test for the equality of variances between groups. Data was 742 
modelled using mixed effects regression models with the outcome ‘LRQ’ and predictor 743 
variables ‘load’ and ‘construct’. Wald statistics were used to indicate significant terms in 744 
the mixed effects model and a chi-square test was used to confirm the significance of the 745 
random effect. A p-value of 0.05 was used to assign statistical significance throughout. 746 
 747 
3.4 Results  748 
At zero load, there was no significant difference in LRQ between the three constructs 749 
(p=0.7) (Figure 1.1). The FASTak II construct produced significantly more abduction 750 
(higher LRQ) compared to both the suture constructs at all loads above zero with the 751 
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difference being largest at 5N (p<0.02). There were no significant differences between the 752 
two suture constructs at any load throughout the study (p>0.05). 753 
 754 
 755 
Figure 1.1: Load versus resultant LRQ for each construct. Stars denote significant 756 
differences between FASTak II and suture constructs (p<0.05). (FASTak was the FASTak 757 
construct, M->L was the medial to lateral suture placement and CdM->CrL was the 758 
caudomedial to craniolateral suture placement) 759 
 760 
 761 
3.5 Discussion  762 
The objective of this study was to determine which of the three prosthesis attachment 763 
techniques evaluated produced the superior mechanical construct. Specifically, we 764 
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attempted to determine which construct produced the greatest arytenoid abduction at the 765 
lowest load.  We proved one hypothesis that the FASTak II anchor would produce the 766 
highest LRQ and disproved our second hypothesis that the more commonly recommended 767 
caudomedial to craniolateral suture placement would be superior to a medial to lateral 768 
angled suture in the arytenoid.  769 
The FASTak II anchor provides a point of attachment for the suture material that is 770 
abaxially located in the muscular process of the arytenoid as compared to the location of 771 
the suture patterns. Such positioning results in less force being required to abduct the 772 
arytenoid because of the effect of the lever arm created by  the cricoid, arytenoid and 773 
cricoarytenoideus articulation.30 This mechanically superior positioning coupled with the 774 
previously reported comparable overall holding strength of a similar type of anchor 775 
compared to suture constructs and ease of placement of the anchor (requires less dissection 776 
in clinical cases) makes its use to attach suture to the muscular process very attractive. In 777 
vivo, the use of the anchor should result in less force needing to be applied to the suture 778 
material to achieve the desired degree of arytenoid abduction and result in a reduced load 779 
on the construct in general. We hypothesise that this should lead to a reduced loss of 780 
abduction due to cartilage or suture failure. 781 
The loads used in this study were similar to those previously reported when evaluating the 782 
cricoid cartilage component of the construct.88,107 Whilst, the lower loads (5N) we reported 783 
to achieve abduction in cadaveric larynges may not transfer directly to the in vivo situation, 784 
the differences seen between the anchor and the suture techniques persisted to relatively 785 
high in vitro loads of 25N. This is not dissimilar to the load of 27.6N that has been 786 
reported to be required to achieve clinically relevant arytenoid abduction, in vivo.88 It is 787 
reasonable to conclude, based on the findings of this study, that using the FASTak II 788 
anchor in vivo may result in a significant reduction in the load required to achieve 789 
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clinically relevant abduction.  This may then result in less clinical abduction failure if there 790 
is less load on the prosthesis.  791 
Gradual loss of arytenoid abduction in the post-operative period occurs in most 792 
laryngoplasty procedures.99 Given this common complication, techniques have been 793 
developed such as mechanical arthrodesis of the cricoarytenoid joint which has been 794 
shown to result in less abduction loss post-operatively74 Other techniques to stabilize the 795 
cricoarytenoid joint have also been reported using laser facilitated surgery or injection of 796 
polymethylmethacrylate. 93,94 These techniques focus on destroying the cricoarytenoid 797 
joint which is still an option when using an anchor such as the FASTak II and indeed 798 
combining the two may result in an even more stable laryngoplasty construct, although this 799 
needs to be further evaluated.  800 
We tested the constructs similar to previously reported models of in vitro evaluation of 801 
arytenoid abduction rather than mount the constructs on a servo hydraulic testing system. 802 
This allowed for the angle of suture distraction to be controlled to very accurately 803 
represent the in vivo positioning, which would not have been as possible on a servo 804 
hydraulic testing system. Also, we chose to test each of the 3 constructs on each of the 805 
larynges to minimize variability in the testing system to allow for a clear understanding of 806 
changing the single variable of how the suture was attached to the arytenoid and what 807 
effect this had on arytenoid abduction. Finally, we measured the degree of abduction using 808 
LRQ rather than cross sectional area (CSA) as this has previously been shown to be a more 809 
accurate measurement tool in vitro compared to CSA.110 810 
There was no difference between the 2 suture patterns tested. Retrospectively this is not 811 
surprising as the bites across the arytenoid, whilst in a different plane, still go across the 812 
body of the arytenoid and the summative effect of the suture loop through the arytenoid 813 
results, mechanically speaking, in the distraction force coming from the middle of the body 814 
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of the arytenoid. As a result, there was no difference between the two patterns in the ability 815 
to achieve arytenoid abduction. Clinically this means that the more important point during 816 
suture placement is achieving a secure bite with the suture and the direction that the suture 817 
is placed across the arytenoid is not important with regards to the load required for 818 
abduction.  819 
Comparison between 3 different techniques of prosthesis attachment to the muscular 820 
process of the equine arytenoid cartilage found there to be significant differences in the 821 
load required to achieve arytenoid abduction.25 In our study, we found that using an 822 
abaxially located anchor such as the FASTak II (Arthrex) resulted in a construct that 823 
achieved abduction whilst requiring the least load. Use of this, or similar, suture anchors 824 
should clinically result in it being easier to obtain the desired degree of intra-operative 825 
arytenoid abduction and result in less initial and ongoing load on the construct. This 826 
reduction in required load should result in a more stable laryngoplasty construct in vivo 827 
with less acute short term and gradual longer term loss of arytenoid abduction.   828 
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PART III: IN VITRO PROTOTYPE EVALUATION STUDIES	  829 
	 56	
Chapter 4: Mechanical testing of a prototype dynamic laryngoplasty system (DLPS) 830 
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4.1 Abstract 844 
Objectives- In vitro biomechanical evaluation of a prototype dynamic laryngoplasty 845 
system (DLPS). 846 
Study Design- Experimental. 847 
Study units- Ten prototype DLPS constructs. 848 
Methods- Ten DLPS constructs were evaluated using an Instron mechanical testing 849 
system. This included sequential testing in 3 stages to assess 1) the amount of distraction 850 
achieved by DLPS activation at a static 10N load, 2) the response to cyclical testing from 851 
10 to 15N and 3) single cycle ramp to 100N.  852 
Results- The DLPS prototype was able to cause 7.11±0.14mm shortening of a suture loop 853 
while under a static 10N load. During cyclical testing, no acute failures occurred and 854 
overall 0.16±0.03mm of construct lengthening was recorded. Nine of the 10 constructs 855 
completed a single cycle ramp loading to 100N without failure, the remaining one device 856 
failed at 38.6N. 857 
Conclusions- The prototype was found to be able to cause an approximately 12% 858 
functional shortening of the suture loop and be able to withstand short term cyclical 859 
loading. Nine of the 10 DLPS prototypes withstood ramp loading considerably above that 860 
reported for in vivo loading on laryngoplasty sutures. Overall, the DLPS performed 861 
sufficiently to justify further evaluation both in vitro and in vivo.  862 
Clinical Relevance- The potential to modify the degree of arytenoid abduction post-863 
laryngoplasty may be a useful tool for equine surgeons considering loss of abduction post-864 
operatively is currently a common complication. 865 
  866 
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4.2 Introduction 867 
Recurrent laryngeal neuropathy (RLN) is a common problem in horses. The prevalence 868 
varies with breed, with rates as high as 10% in Thoroughbreds and 42% in draft horses.26,31 869 
The laryngoplasty (LP) technique described by Marks et al. in 1970 is currently the 870 
treatment of choice for RLN in racehorses.65 Complications following LP in horses are 871 
many and varied and have been reported extensively.99,102 With the current LP technique, it 872 
is a challenge during surgery to achieve the “ideal” degree of abduction to maximise 873 
respiratory function whilst avoiding complications associated with this static position of 874 
the arytenoid abduction. The basic premise of laryngoplasty is the use of a prosthetic 875 
material to pull the arytenoid into abduction and maintain it statically in that position. This 876 
underlying principle has not changed but there have been multiple variations developed 877 
and evaluated.71,73,75,80,96,105 All of these LP system variations have been aimed at 878 
attempting to maximise the stability of the static LP construct (i.e. arytenoid abduction).  879 
The focus of the research we report here was to evaluate a prototype dynamic 880 
laryngoplasty system (DLPS) in vitro. This DLPS was developed with the goal of being 881 
able to selectively alter the degree of arytenoid abduction in the horse after surgery. This 882 
device could have a number of advantages compared with the traditional LP. It could be 883 
used to optimise arytenoid cartilage positioning in the immediate post-operative period. 884 
Alternatively, it could be used to allow for correction of the gradual loss of abduction that 885 
occurs post-operatively.111 Finally, it might allow the arytenoid to be maintained in a 886 
relatively adducted position at rest and be altered, to a maximally abducted position, when 887 
peak airflow is required during exercise. Overall, an option to alter the degree of abduction 888 
post-operatively may lead to reduced complications and potentially allow for improved 889 
respiratory function during maximal exercise.  890 
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The developed DLPS prototype allows for shortening of a traditional laryngoplasty suture 891 
loop by means of a balloon constrained within a custom designed polyether ether ketone 892 
(PEEK) device (Figure 1).  893 
 894 
 895 
Figure 1. Diagram form of how the prototype functions by inflation of the balloon (red) 896 
between the 6cm long suture loop (blue) causing shortening as a result (functional 897 
shortening=6cm-Xcm). Black circles indicate points of attachment to mechanical testing 898 
machine.  899 
 900 




   
X cm





The device is designed to have a minimal profile and dimensions to suit the anatomic site 902 
of placement: specifically, to fit within the space bounded by the caudal aspect of the 903 
cricoid and the muscular process in a fully abducted position and from the sagittal ridge of 904 
the cricoid to the wing of the thyroid cartilage. The DLPS can be inflated or deflated using 905 
saline injected via an attached catheter that could eventually be attached to a subcutaneous 906 
injection port allowing for minimally invasive post-operative alteration of arytenoid 907 
abduction.  908 
Prior to further testing of the DLPS prototype we wanted to determine its performance 909 
using a mechanical testing unit. Our aims were to 1) determine the degree of construct 910 
shortening that was possible using the DLPS, 2) evaluate the DLPS during cyclical loading 911 
and 3) evaluate the DLPS during a single cycle to failure. 912 
We hypothesised that the DLPS would 1) be able to effectively shorten the LP suture 913 
construct (greater than 10% shortening of the suture loop), 2) maintain construct 914 
shortening during cyclical testing (less than 1% increase in suture loop whilst the device is 915 
activated) and 3) not fail during single cycle ramp testing. 916 
 917 
4.3 Materials and Methods  918 
Ten DLPS constructs were evaluated. All testing was performed using a servohydraulic 919 
testing machine (Instron, Norwood, MA) linked to a data acquisition program 920 
(LabChartÔ). For each test a new single strand of #2 Ethibond Excel ([5 metric] Ethicon 921 
Inc, NJ) was used to form a 6cm loop (total suture length 12cm) which was passed through 922 
2 metal eyelets rigidly affixed to the loading arms of the mechanical testing machine and 923 
tied using standard technique to mimic a laryngoplasty suture loop. The selected DLPS 924 
prototype was then instrumented in the 6cm loop and connected to an adjustable pressure 925 
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syringe (Blue DiamondÔ Merit Medical) (Figure 2). Each DLPS construct was 926 
sequentially tested in 3 stages; 1) static load-distraction, 2) cyclical testing and 3) single 927 
cycle ramp to 100N. 928 
 929 
Figure 2. Picture on left demonstrates construct positioning for testing and the PEEK 930 
component of the DLPS in schematic form on the right. 931 
 932 
 933 
4.3.1 Static load – distraction testing 934 
Each DLPS construct was loaded to 10N and maintained at this load. The loss of 935 
distraction (construct shortening) required to maintain the target 10N load caused during 936 
sequential DLPS activation at 10psi increments to a maximum of 60psi as measured using 937 









4.3.2 Cyclical testing 940 
With the DLPS activated at 50psi the load on the construct was cycled from 10 to 15 N at a 941 
rate of 1 cycle per 1 second (1Hz) for 30 minutes (total 1800 cycles). The distraction that 942 
occurred over the duration of this testing was recorded. 943 
 944 
4.3.3 Single cycle testing 945 
With the DLPS activated at 50psi the load was ramped to failure or 100N load (whichever 946 
occurred first) at a rate of 0.83mm/s (50mm/min). From the generated load-distraction 947 
curves, the load at failure (N) and stiffness (N/mm) were calculated for each construct.  948 
 949 
All data is reported as mean ± SEM throughout unless otherwise stated.  950 
 951 
 952 
4.4 Results  953 
4.4.1 Static load – distraction testing 954 
All constructs completed testing without failure at the target load of 10N. The DLPS 955 
caused a maximal shortening of the construct length of 7.11±0.14mm (Figure 3). This 956 
equates to an effective 11.85% shortening of the 60mm long suture loop by maximal 957 
activation of the DLPS. Further pressure increases were not possible due to the suture 958 
material disengaging with the DLPS device or prolapsing off the DLPS balloon around the 959 
suture.  960 
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 961 
Figure 3. Mean (+/- SEM) Distraction achieved during static load testing of 10 DLPS 962 
constructs at 10psi increments. 963 
 964 
4.4.2 Cyclical testing 965 
All constructs completed testing without failure. Over the 1800 cycles (30 minutes at 1Hz) 966 
there was an average increase of 0.16±0.03mm in construct length. The minimum and 967 
maximum load during testing was tightly controlled and was on average 9.82±0.10N and 968 
15.37±0.28N respectively.  969 
 970 
4.4.3 Single cycle testing 971 
Nine of the 10 DLPS constructs were loaded to 100N without failure and the testing was 972 
stopped due to load cell restrictions at that point. The stiffness for these 9 constructs was 973 
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11.35±0.63N/mm. The remaining single DLPS construct failed due to balloon rupture at 974 
38.6N and most likely occurred due to the balloon pinching against the DLPS implant. 975 
 976 
 977 
4.5 Discussion  978 
We evaluated a novel DLPS in vitro using a series of mechanical tests to determine the 979 
performance of this device in a simulated equine laryngoplasty suture loop. The DLPS was 980 
able to cause shortening of the suture loop, withstand cyclical loading for 180 cycles and 9 981 
of the 10 DLPS withstood 100N of load without failure. Based on this in vitro evaluation 982 
further evaluation of the DLPS is warranted. 983 
 984 
Our first goal was to determine what degree of shortening was possible using a suture loop 985 
similar to a laryngoplasty construct in vivo using the DLPS. A 6cm loop of suture was 986 
selected based on previous measurements of 10 adult equine cadaveric larynges which had 987 
an average cricoid length at the dorsal midline of 5.3±0.7cm resulting in a laryngoplasty 988 
suture loop length of approximately 6cm (Ahern, unpublished data). The selection of a 989 
static force of 10N to test the degree of distraction that the DLPS could generate was based 990 
on previous in vivo and in vitro work.88,89,112,113 The force on the laryngoplasty suture in 991 
vivo when placed with the animal under general anaesthesia has been reported to be 992 
27.6±7.5N.88 However, recently during standing laryngoplasty the force required to obtain 993 
abduction was subjectively lower in comparison.72,88 In vitro, much lower force (14.7N in 994 
one study) has been reported to be required to achieve arytenoid abduction.89 These 995 
reported forces were measured using a traditional laryngoplasty suture placement through 996 
the muscular process. The use of a suture anchor to position the point of distraction in a 997 
mechanically superior position (more abaxially) will likely result in less force being 998 
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required to achieve effective abduction and, as a result, 10N was selected for this testing.113 999 
Based on these parameters the DLPS was able to cause 7.11mm of shortening, or almost 1000 
12% reduction of the overall length of the construct.  1001 
 1002 
The second goal was to evaluate the DLPS prototype during cyclical loading. The cyclic 1003 
load was from 10 to 15 N at 1Hz. This rate of 1Hz was selected to ensure the Instron 1004 
machine maintained a high level of accuracy at these relatively low loads. Using this 1005 
cyclical testing for a period of 1800 cycles was completed successfully with a very small 1006 
amount of total distraction (0.16mm or 0.26% of overall length). This number of cycles 1007 
was similar to previously reported for in vitro laryngoplasty testing with the rate of loading 1008 
slightly lower.75 Laryngoplasty sutures have been shown to undergo loading a mean of 1009 
1152 times in a 24 hour period.88 As a result, the 1800 cycles used for this in vitro testing 1010 
equates to slightly more than 1.5 days of cyclical testing seen in vivo. Using this in vitro 1011 
model of testing the prototype was able to withstand cyclical loading sufficiently in the 1012 
short term to justify further research. 1013 
 1014 
The third and final goal was to evaluate the prototype during a single cycle test to a 100N 1015 
load which is a considerably higher load that is likely to occur in vivo at any point.88 One 1016 
prototype failed at 38.6N and this appeared to be due to pinching of the balloon component 1017 
of the DLPS against the PEEK. Smoothing of the PEEK portion of the device for mild 1018 
manufacturing blemishes will likely resolve this problem. Another factor to consider is that 1019 
using the DLPS prototype, the in vivo maximal load may not be as high as the previously 1020 
reported 46.6N (recorded during induced swallowing) due to differences in the way the 1021 
laryngoplasty was performed between these studies. Specifically, the use of an anchor for 1022 
the arytenoid attachment has been shown to reduce the force required to achieve abduction 1023 
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by 50% compared to a traditional suture placement.91 Following on from this reduced load 1024 
to achieve abduction it is possible that the peak load may be lower than the reported 46.6N.  1025 
If the peak load is indeed lower than the 46.6N as a result of using the anchor then the 1026 
DLPS failure that occurred at 38.6N is likely to be above the expected in vivo loading. As 1027 
such, all 10 DLPS devices would have failed at loads above the expected in vivo 1028 
conditions. However, the maximal in vivo load using an anchor as a component of a 1029 
laryngoplasty is unknown and would be an interesting direction of future research.  1030 
 1031 
Laryngoplasty techniques based on the procedure originally developed by Marks et al in 1032 
1970 have undergone extensive in vitro and in vivo evaluation. The underlying principle of 1033 
placing a prosthetic material(s) from the muscular process of the arytenoid to the caudal 1034 
aspect of the cricoid has remained uniform throughout. Variations have been many and 1035 
varied from originally Lycra to various types of suture material and even zip-ties.65,73,80,105 1036 
The laryngoplasty has been associated with success rates ranging from 45-70% in flat 1037 
racehorses.57,67,77,114 The most common and significant complications associated with the 1038 
procedure are loss of post-operative abduction and airway contamination (coughing / 1039 
dysphagia).99,102 The development of a laryngoplasty system such as the DLPS evaluated 1040 
in this research should as a minimum allow for post-operative surgical abduction 1041 
modification / maintenance or ideally the ability to change the degree of arytenoid 1042 
abduction longer term based on the specific exercise requirement of a horse at any 1043 
particular time.  1044 
 1045 
This research evaluated the mechanical function of a prototype DLPS in vitro to determine 1046 
the device’s ability to cause functional shortening of a simulated laryngoplasty construct 1047 
and withstand physiologically relevant loading. The results of this research indicate that 1048 
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the further development and evaluation of the DLPS as a means to achieve dynamic 1049 
arytenoid positioning is warranted.  1050 
  1051 
	 69	
Chapter 5: In vitro evaluation of the effect of a prototype dynamic laryngoplasty system 1052 
(DLPS) on arytenoid abduction 1053 
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5.1 Abstract 1068 
Objectives- To evaluate the ability of a prototype dynamic laryngoplasty system (DLPS) 1069 
to affect arytenoid abduction in vitro.  1070 
Study Design- Experimental. 1071 
Study population- Cadaveric larynges from 10 adult Standardbred and Thoroughbred 1072 
racehorses. 1073 
Methods- Dissected larynges were mounted and the right arytenoid maximally abducted 1074 
for subsequent testing.  A left sided laryngoplasty was performed using a single strand of 1075 
#2Fiberwire and a FASTak®II suture anchor. Phase 1 of testing involved progressively 1076 
shortening (tightening) the suture, without the DLPS device in place, in 1 mm increments 1077 
and acquiring a digital image of the rima glottidis at each increment. Phase 1 was used to 1078 
assess the amount of shortening required to achieve full arytenoid abduction and as a frame 1079 
of reference for the results of subsequent testing. Phase 2 involved completing the 1080 
laryngoplasty (tying the suture) at a target left to right quotient (LRQ) angle of 0.7 with the 1081 
DLPS in place. Subsequently, digital images at 3 stages of DLPS activation (0, 25 and 50 1082 
or maximal psi when 50 was not achieved) were obtained. All digital images were stored 1083 
and analysed to generate LRQ angles as a measure of arytenoid abduction.   1084 
Results- One larynx during dissection was found to have laryngeal dysplasia and was 1085 
excluded. The remaining 9 larynges were anatomically normal and all aspects of testing 1086 
were completed. In Phase 1, a total shortening of 25.89±1.27mm was possible and this 1087 
increased the LRQ from 0.59±0.02 to a maximum of 1.07±0.12. In Phase 2, activation of 1088 
the DLPS caused the LRQ to increase from 0.70±0.05 to a maximum of 0.97±0.09. This 1089 
change in LRQ equated to 18.7mm of effective shortening based on Phase 1 results.  The 1090 
maximum psi before the balloon element of the DLPS prolapsed was 37.33±5.96. 1091 
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Conclusions- The DLPS was able to increase the degree of arytenoid abduction in vitro. 1092 
This increase in LRQ was equivalent to 18.7mm of effective shortening of the 1093 
laryngoplasty suture loop based on Phase 1 of the study.  1094 
Clinical relevance- The DLPS may allow for adjustment of the degree of arytenoid 1095 
abduction post-operatively. The results presented here support further evaluation of the 1096 
device in vitro and ultimately in vivo.  1097 
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5.2 Introduction  1098 
Recurrent laryngeal neuropathy (RLN) is a common problem in horses.26,31 The traditional 1099 
laryngoplasty (LP) technique was first described by Marks et al. in 1970 and is still 1100 
considered to be the treatment of choice for this condition in athletic horses.65 There is a 1101 
relatively high incidence of complications associated with this procedure, which have been 1102 
associated either with under or over abduction of the surgically abducted arytenoid.99-102 1103 
Furthermore, some degree of failure as measured by loss of arytenoid abduction has been 1104 
reported to occur in nearly all cases.111 The most commonly reported complications related 1105 
to over abduction include coughing and/or aspiration.68,99,102 1106 
The surgical procedure of LP as described by Marks et al. (1970) has undergone 1107 
remarkably little variation when compared to the modern reported variations. Overall the 1108 
common principle of all traditional laryngoplasty techniques is to replace the action of the 1109 
cricoarytenoideus (CAD) muscle to achieve arytenoid abduction using single or multiple 1110 
prostheses. Over the years there has been considerable research into and variation of 1111 
various components of the laryngoplasty procedure with the research focusing on 1112 
achieving static abduction of the arytenoid with no or minimal loss of abduction in the 1113 
post-operative period.71,73-75,80,96,105,112  1114 
The overarching objective of our research was to develop a means for performing a 1115 
laryngoplasty with the ability to alter the degree of arytenoid abduction selectively after 1116 
surgery. With this aim in mind we developed a dynamic laryngoplasty system (DLPS) that 1117 
we have evaluated in vitro via mechanical testing. This testing found the DLPS when 1118 
activated was able to produce 7.11mm (12%) of suture loop shortening at a static 10N 1119 
load. Furthermore, the DLPS was able to withstand 100N ramp loading without failure in 1120 
9/10 tests. Finally, cyclical testing resulted in 0.16mm (0.26%) of distraction loss during 1121 
1800 cycles.115 Based on these encouraging mechanical testing results, the next step and 1122 
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the focus of this research was to evaluate the ability of the DLPS prototype to achieve 1123 
changes in arytenoid abduction in vitro using cadaveric larynges.  1124 
There were two aims of this study. The first aim (Phase 1) was to evaluate the relationship 1125 
between shortening of the laryngoplasty suture (without the DLPS in place) and LRQ 1126 
change, with the goal of assessing the amount of shortening required to achieve full 1127 
arytenoid abduction and as a frame of reference for comparison with the results from the 1128 
second phase of the study. The second aim (Phase 2) was to evaluate the relationship 1129 
between DLPS activation and LRQ change.  1130 
We hypothesised that activation of the DLPS would cause a change in LRQ of greater 1131 
effect than the equivalent of LRQ change caused by 7.11mm of construct shortening.  1132 
 1133 
 1134 
5.3 Materials and Methods  1135 
5.3.1 Specimen preparation and positioning 1136 
Larynges from 10 Standardbred and Thoroughbred horses aged 3-11 years euthanized for 1137 
reasons other than respiratory disease were collected and frozen at -200C. Larynges were 1138 
then thawed at room temperature for 24 hours immediately prior to testing. The thyroid, 1139 
cricoid, epiglottic and arytenoid cartilages and their intrinsic muscles were retained for 1140 
testing, with the other soft tissue removed. The cricoid length at the dorsal midline was 1141 
measured using callipers and recorded for each larynx. Each larynx was positioned in a 1142 
standardised manner: mounted in a customized cradle as previously reported98 and 1143 
positioned 30 cm from a digital camera (HC-V250 high definition digital camera, 1144 
Panasonic, Osaka, Japan) that was controlled remotely using generic wireless technology. 1145 
A 10-cm ruler was affixed in the same plane as the laryngeal opening as a reference in the 1146 
digital image. 1147 
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 1148 
5.3.2 Laryngoplasty suture placement 1149 
For each larynx, the right arytenoid was maximally abducted and fixed in position for all 1150 
testing as reported.91,116 The left side had a #2 Fiberwire suture (removed from the 1151 
preloaded position in a FASTak®II (AR-1324HF, Arthrex)) placed through the cricoid 1152 
cartilage 1.5cm lateral to the midline and 1.5cm from the caudal edge. For the arytenoid 1153 
attachment the FASTak®II suture anchor was placed in the arytenoid 10mm cranial to the 1154 
insertion of the CAD muscle as previously described. 91,113 The suture was then threaded 1155 
through the eyelet of the anchor from medial to lateral such that the two threads ends were 1156 
in a relatively lateral position creating a single suture loop. 1157 
 1158 
5.3.3 Phase 1 testing – suture shortening 1159 
For Phase 1 testing, the ends of the suture at the mid-point (from cranial to caudal) of the 1160 
cricoid cartilage were attached to the arms of a Vernier calliper to allow for progressive 1161 
controlled construct shortening at 1 mm increments by opening the calliper arms (Figure 1162 
1). Digital images were obtained at each 1mm of construct shortening to assess progressive 1163 




Figure 1. Position of callipers to allow for progressive shortening of the laryngoplasty 1167 
construct.  1168 
 1169 
5.3.4 Phase 2 testing – DLPS activation 1170 
Immediately following Phase 1 testing of each larynx, the suture was tied routinely with a 1171 
surgeon’s knot and 4 single throws to the left arytenoid at an approximate LRQ of 0.7. 1172 
Subsequently, the DLPS was inserted in position between the two suture threads. The 1173 
associated 30cm long catheter with the attached injection port was located so that handling 1174 
of the injection port did not alter the position of the larynx.  Three states were tested; 1175 
“inactivated” (no saline injection - 0 psi) and 2 levels of activation (25psi and 50 psi). The 1176 
25 psi and 50 psi pressures of activation were achieved by injecting saline into the 1177 
injection port and the pressures were selected based on the previous mechanical testing 1178 
results.115 As previously reported, the injection pressure was measured using a pressure 1179 
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syringe (Blue DiamondÔ Merit Medical).115 If a pressure of 50psi was not achieved the 1180 
maximal pressure was recorded and the reason for failure to achieve 50psi recorded. 1181 
Digital images were obtained at each of the 3 levels (Figure 2).  1182 
 1183 
Figure 2. Larynx mounted for testing showing 0, 25 and 50 psi activation of the DLPS 1184 
from left to right respectively.  1185 
 1186 
5.3.5 Left to Right Quotient angle ratio (LRQ) 1187 
Arytenoid LRQ was measured and calculated as previously described from each 1188 
photograph by one observer (B.A.) using a soft-ware package (Image J, Bethesda, 1189 
USA).51,110 In short, a line was drawn from the ventral to the dorsal aspect of the rima 1190 
glottis and then extended by one third to give a point that was used to measure the left (LO) 1191 
and right (RO) arytenoid angles. The LRQ was then calculated by dividing LO from RO. 1192 
 1193 
5.3.6 Statistical analysis 1194 
Multivariable logistic regressions using ordinary least squares were used to a) fit the LRQ 1195 
to amount of laryngeal shortening (mm) and b) fit the LRQ to DLPS pressure (psi) for each 1196 
larynx used.  Predicted estimates of the observed values were produced and used to 1197 
calculate the line of best fit with 95% confidence intervals. All analyses utilised a 5% two-1198 
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tail probability point as the basis for rejection of null hypotheses of no difference from a 1199 
zero value (slope).  Stata version 14.1 was used for all analysis and data is reported as 1200 
mean ± SD. Graphs are presented with 95% confidence intervals. 1201 
 1202 
5.4 Results  1203 
During dissection one larynx was found to have abnormal anatomy consistent with 1204 
laryngeal dysplasia and was excluded from testing. All remaining 9 larynges were 1205 
anatomically normal and completed testing without problems associated with mounting, 1206 
image acquisition or LRQ calculation. The 9 larynges had a dorsal cricoid length of 1207 
52.28±2.36mm. 1208 
For phase 1 of testing a total shortening of 25.89±1.27mm was achieved which resulted in 1209 
the LRQ increasing from a baseline of 0.59±0.02 to a maximum of 1.07±0.12. This was a 1210 
mean increase in LRQ of 0.47±0.12. The linear regression for all data points produced a R2 1211 
value of 0.91 (Figure 3). A maximum of 25.89±3.82mm of suture shortening was possible 1212 
before further shortening did not cause additional increases in LRQ. 1213 
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 1214 
Figure 3. Linear regression of progressive suture shortening and resultant LRQ. Data 1215 
reported as mean ± SD with 95%CI. 1216 
 1217 
For phase 2 of testing, the DLPS was instrumented to the left side of the larynx between 1218 
the two suture loops without complication in all cases. Activation of the DLPS resulted in 1219 
an increase in LRQ from 0.70±0.05 (0 psi) to a maximum of 0.97±0.09 (p<0.001) (Figure 1220 
4). This change in LRQ equated to 18.7mm of effective shortening based on linear 1221 
regression of the phase 1 results. Eight of the 9 DLPS failed to reach the target of 50 psi 1222 
because in all cases the balloon component became overinflated and prolapsed from the 1223 
device after protruding from the rigid portion of the DLPS. Additional injections of saline 1224 
did not result in further increases in LRQ or pressure once the prolapse occurred. The 1225 




Figure 4. Linear regression of activation pressure and resultant LRQ. Data reported as 1229 
mean ± SD with 95%CI.	1230 
	1231 
	1232 
5.5 Discussion  1233 
We evaluated in vitro a novel DLPS that allowed for selective alteration of the degree of 1234 
arytenoid abduction using inflation via an injection port. This device has been developed 1235 
as a potential method that could be used to selectively alter the degree of arytenoid 1236 
abduction after laryngoplasty surgery. This option may be useful to optimise post-1237 
operative arytenoid abduction and potentially reduce complications associated with 1238 
suboptimal (over or under) abduction.  1239 
This in vitro evaluation was essential to confirm the deliverability of the device and 1240 
relative performance using cadaveric larynges. Previous mechanical testing evaluation of 1241 
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the DLPS found that the device could cause functional shortening of 7.11m of a suture 1242 
loop under a static load of 10N. Furthermore, the device was able to withstand ramp to 1243 
100N failure in 9/10 tests and had minimal displacement with cyclical testing.115 This 1244 
research aimed to build on these earlier mechanical testing results by evaluating the DLPS 1245 
using cadaveric larynges. This phase of evaluation of the DLPS was important to ensure 1246 
the device could cause alteration in arytenoid position in normal cadaveric larynges.  1247 
The 9 larynges used in this study were obtained from adult Thoroughbred and 1248 
Standardbred horses with no visual evidence of laryngeal abnormalities. We elected to use 1249 
LRQ as a means of evaluating change in arytenoid abduction similar to previous 1250 
studies.51,74,94,110 We selected LRQ because as long as the camera position and laryngeal 1251 
position are fixed and uniform, as was the case in this testing, then minor variations in the 1252 
original position of the larynx or camera do not affect the results.  A similar means of in 1253 
vitro testing using LRQ has been previously reported.91,110 Cross sectional area of the rima 1254 
glottis would have been an alternative method of measuring arytenoid abduction 1255 
comparatively but based on previous research comparing the two methods there is no 1256 
significant difference and due to the simplicity and robustness of LRQ measurements this 1257 
was selected.51  1258 
The first phase of this study was performed to assess the amount of shortening required to 1259 
achieve full arytenoid abduction and serve as a frame of reference for the results of phase 2 1260 
testing. During this phase 1, shortening of the suture loop using callipers without the DLPS 1261 
in place, caused relatively consistent and linear (R2=0.91) increases in LRQ up to between 1262 
25-30 mm of shortening. At that maximal degree of shortening further efforts to shorten 1263 
the loop did not cause additional increases in LRQ and represented the maximal range of 1264 
suture shortening possible which was limited by the relative anatomic dimensions of the 1265 
larynx.  1266 
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In the second phase of the study we evaluated the DLPS at three levels, based on the 1267 
mechanical testing results to reflect what we considered to be baseline or inactivated 1268 
(0psi), moderate activation (25 psi) and maximal activation (50 psi). We selected an 1269 
inactivated target LRQ of 0.7 in an effort to represent a low to moderate level of arytenoid 1270 
abduction that might represent the lower end of a spectrum of arytenoid abduction 1271 
surgeons might aim for clinically when performing a laryngoplasty.4,56,68 As a result, a 1272 
LRQ of 0.7 was selected to represent a level at which the DLPS might be used clinically to 1273 
increase arytenoid abduction post-operatively. This study evaluated the DLPS ability to 1274 
cause this increase in LRQ from 0.7 with 2 levels of activation. 1275 
Activation by injection in the port was readily achieved using saline and caused significant 1276 
increases in LRQ with increasing pressure. Using the linear regression model from Phase 1277 
1, the increase in LRQ by maximal activation corresponded with 18.7mm of suture 1278 
shortening. This was more than the 7.11mm of suture shortening found in the previous 1279 
mechanical testing study when tested at a static load of 10N. The result of this study 1280 
supported our hypothesis that activation of the DLPS would cause a change in LRQ of 1281 
greater effect than the equivalent of LRQ change caused by 7.11mm of construct 1282 
shortening. The degree of LRQ change and corresponding suture shortening was 1283 
considerably higher than during the previous mechanical testing. This is due to the 1284 
cadaveric nature of this research where there are relatively little forces restricting arytenoid 1285 
abduction. In an in vivo situation the arytenoid would be subject to adduction forces seen 1286 
with coughing, swallowing or negative airway pressures which may mean the DLPS used 1287 
in vivo may be less able to achieve the increases in arytenoid abduction seen in this in vitro 1288 
study, although this is unknown at this time.88 However, due to the use of an anchor in the 1289 
arytenoid which has been shown to reduce the load on the laryngoplasty suture by 1290 
approximately 50% the exact effect of these forces is as yet undetermined.91 Before in vivo 1291 
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testing, the next step in evaluating the DLPS should involve further in vitro testing using 1292 
an airflow model, similar to previously reported studies, to simulate the negative airway 1293 
pressures seen in vivo. 74,86,94 1294 
The balloon component of the DLPS was found to prolapse and not cause further increases 1295 
in LRQ at pressures between 30-40 psi. This was due to the DLPS having produced 1296 
maximal shortening of the suture and represents the maximal amount of construct 1297 
shortening achievable in vitro. As a result, it may be useful in vivo to monitor the injection 1298 
pressure, or, the endoscopic appearance and when there is a plateau of pressure or in 1299 
arytenoid abduction, then this will likely represent the point of maximum performance of 1300 
the DLPS. With regards to monitoring the pressure the effect of soft tissue surrounding the 1301 
DLPS in vivo is as yet unknown and may potentially limit prolapse of the balloon element, 1302 
which may alter the pressure required to achieve full activation. As a result, the 1303 
combination of endoscopic and pressure monitoring in conjunction may be the most ideal.  1304 
In conclusion, we found the prototype DLPS was able to effectively achieve significant 1305 
increases in arytenoid abduction in vitro. We supported our hypothesis by finding the 1306 
DLPS was able to cause arytenoid abduction equivalent to 18.7mm of shortening which 1307 
was more than the 7.11mm found in previous mechanical testing research. These results 1308 
support the further evaluation of this device with an overarching objective of trying to 1309 
develop a clinically useful means of selectively altering the degree of arytenoid abduction 1310 
post-operatively.   1311 
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Chapter 6: Evaluation of a prototype dynamic laryngoplasty system (DLPS) in vitro 1312 
using an equine vacuum airflow system 1313 
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6.1 Abstract 1331 
Objectives- Evaluation of a prototype dynamic laryngoplasty system (DLPS) in vitro 1332 
using an static airflow model.   1333 
Study Design- Experimental. 1334 
Study units- Cadaveric larynges from 10 adult Standardbred and Thoroughbred horses. 1335 
Methods- Dissected larynges were mounted within the testing system with the right 1336 
arytenoid maximally abducted for all testing. A left-sided laryngoplasty using a single 1337 
strand of #2Fiberwire and a FASTak®II suture anchor was performed. Each larynx was 1338 
tested using a static airflow model in 2 phases. Immediately prior to testing of each larynx, 1339 
the system was adjusted to produce a standard 55 L/s flow rate and a pre-laryngeal 1340 
pressure of 12 mmHg whilst both arytenoids were maximally abducted. For phase 1 of 1341 
testing the suture loop was progressively shortened (tightened), in 3 mm increments from 0 1342 
mm to 30 mm and the larynx tested at each increment. In phase 2 the variable balloon 1343 
portion of the DLPS was inserted and three stages of DLPS activation (inactivated [0], 25 1344 
and maximal psi) were tested. Each test was a 5 second period of static airflow as outlined 1345 
above. Translaryngeal impedance (TLI), left to right quotient angles (LRQ) and cross 1346 
sectional areas (CSA) were calculated for each test.  Data is reported as mean +/- SEM. 1347 
Results- Activation of the DLPS caused increases in both CSA and LRQ (p<0.05). 1348 
Translaryngeal impedance was significantly reduced by suture tightening up to 6mm, but 1349 
not by additional shortening (p=0.001). In the second phase of the study, activation of the 1350 
DLPS prototype caused a significant reduction in TLI from no activation (0 psi) 1351 
(0.43±0.08mmHg/L/sec) to 25 psi (0.16±0.04mmHg/L/sec, p<0.001) and a smaller but 1352 
non-significant additional reduction (0.13±0.03mmHg/L/sec) at maximal activation.  1353 
Conclusions- The prototype DLPS was able to cause significant reductions in TLI by 1354 
activation from 0 to 25 psi and a further smaller non-significant reduction at maximal psi. 1355 
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Clinical Relevance- The DLPS prototype in this in vitro airflow system was shown to be 1356 
able to achieve and maintain arytenoid abduction that was beneficial to airflow. Based on 1357 
these results further evaluation in vivo is supported.   1358 
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6.2 Introduction  1359 
Recurrent laryngeal neuropathy (RLN) is a common problem in horses.26,31 The currently 1360 
recommended treatment of choice for this condition in athletic horses is a prosthetic 1361 
laryngoplasty (LP) based on the technique originally described by Marks et al in 1362 
1970.26,31,65 This LP technique fundamentally aims to produce static abduction of the 1363 
arytenoid thereby preventing arytenoid cartilage collapse during exercise. Recent 1364 
modifications of the LP have focused on different prosthesis materials, different methods 1365 
to anchor to the cartilage, and evaluated different methods to fuse the cricoarytenoideus 1366 
articulation.71,74,93,94,113 Overall, the reported success rate for LP surgery for racehorses has 1367 
been reported to be in the range of 38-78%.106  1368 
Our group has aimed to develop a LP technique that allows for alteration of the degree of 1369 
arytenoid abduction post-operatively to maximise efficacy and minimise complications. 1370 
This would ideally allow for a more dynamic, or adjustable, degree of arytenoid abduction 1371 
that could be customised to a particular horses’ airway requirements. This effort to develop 1372 
an adjustable LP is based on the fact that when a LP is performed the majority of horses 1373 
will develop a loss of arytenoid abduction by 1-2 grades within the first 6 weeks.111 This 1374 
loss of abduction can be quite variable and presents a challenge to surgeons who are 1375 
aiming for the target degree of arytenoid abduction that equates to 88% of the cross 1376 
sectional area of the rima glottidis based on computational modelling of airflow.21 Based 1377 
on previous in vitro testing by our group this suggested 88% CSA equates to an 1378 
approximate LRQ of 0.7-0.75 (data not shown).  To achieve these targets clinically it can 1379 
be tempting to over-abduct the arytenoid at surgery and then rely on post-surgical 1380 
abduction loss to occur and “settle” to the desired arytenoid position. However, 1381 
complications such as coughing and aspiration pneumonia have been attributed to over 1382 
abduction of the arytenoid.73,78,88,99,117 Additionally, some of these complications such as 1383 
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coughing have been found to put greater pressure on the prosthesis which can lead to either 1384 
cartilage or LP failure.99 Due to these considerations, the ability to alter the degree of 1385 
abduction post-operatively to customise the degree of arytenoid abduction may provide a 1386 
useful option for equine surgeons performing LPs. 1387 
Previously, our group has developed a prototype dynamic laryngoplasty system (DLPS) 1388 
and evaluated it to ensure the device was capable of withstanding reasonable loading 1389 
conditions whilst mounted on a mechanical testing machine. That research found the 1390 
device was able to produce 7.11mm of construct shortening at a constant load of 10N, 1391 
which was selected to approximate loading expected in vivo based on previous research. 1392 
Subsequently, the DLPS was evaluated in vitro using cadaveric larynges to determine the 1393 
ability of the device to alter the degree of arytenoid abduction within the specific anatomy 1394 
of the equine larynx. That research found the prototype was able to achieve 18.7mm of 1395 
effective shortening and significantly increase the degree of arytenoid abduction as a 1396 
result. 1397 
The aim of this study was to evaluate the ability of the DLPS prototype to affect and 1398 
maintain a reduction in translaryngeal impedance (TLI) using a static airflow model 1399 
similar to previously reported systems, as a final step prior to in vivo testing.74,86,94,116  1400 
For this study, we had two hypotheses. Firstly (1), that activation of the DLPS would 1401 
reduce TLI during airflow testing compared to no activation. Secondly (2), we 1402 
hypothesised that activation of the DLPS would prevent dynamic collapse of the rima 1403 
glottis during airflow testing. 1404 
 1405 
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6.3 Materials and Methods  1406 
6.3.1 Specimen preparation 1407 
Larynges and a segment of attached trachea from 10 Standardbred and Thoroughbred 1408 
horses aged 3-11 years were collected and frozen at -200C. The larynges were then thawed 1409 
at room temperature for 24 hours immediately prior to testing. Once the larynges were 1410 
confirmed to have grossly normal anatomy, the thyroid, cricoid, epiglottic, arytenoid 1411 
cartilages, 2 tracheal rings and all intrinsic muscles were retained for testing, with all other 1412 
soft tissue removed. The left cricoarytenoideus dorsalis (CAD) muscle was transected 1413 
immediately caudal to its insertion on the muscular process of the arytenoid cartilage prior 1414 
to testing. 1415 
 1416 
6.3.2 Suture placement 1417 
For each larynx, the right side was fixed in a maximally abducted position for all of the 1418 
testing.91,116 As previously reported, for the left sided LP, #2 Fiberwire suture (Arthrex™) 1419 
was passed using a trocar point half circle needle through the cricoid cartilage 1.5 cm 1420 
lateral to the midline and 1.5 cm from the caudal edge.91 For the arytenoid attachment a 1421 
FASTak®II (AR-1324HF, Arthrex™) suture anchor was placed in the arytenoid 10 mm 1422 
cranial to the insertion of the CAD muscle as previously described.91,113 The suture was 1423 
then threaded through the eyelet of the anchor from medial to lateral such that the two 1424 
thread ends were in a relatively lateral position creating a single suture loop. 1425 
 1426 
6.3.3 Vacuum Chamber Model 1427 
A unidirectional vacuum system based on the in vitro models reported by Cheetham et al. 1428 




Figure 1. Model set-up for airflow testing showing the plastic box with the test larynx 1432 
inside connected to the vacuum cleaners. The camera is mounted with lights focused on the 1433 
larynx to ensure a clear image with no shadows for easy evaluation. 1434 
 1435 
To achieve a variable flow rate, two vacuum / blowers (Ryobi 2400W 230-240V 50 Hz), 1436 
set on vacuum mode controlled using a variable autotransformer (Variac, Powertech SRV-1437 
5), attached to a ergospirometer (Quadflow Equine Spirometry, QF, RobacScience Pty 1438 
Ltd) were connected via a 50mm PVC pipe to the testing chamber. The chamber was 1439 
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15x15x30cm with a 50mm hole at both ends of the chamber to allow for insertion of the 1440 
50mm pipe attached to the vacuum system and a variable inlet valve at the other end. A 1441 
hole was drilled into the dorsal surface of the 50mm PVC pipe and into the flow chamber 1442 
cranial to the position of the larynx to insert the catheters of the differential pressure 1443 
transducer (Digitron Differential Pressure Transducer). Each larynx was affixed to the 1444 
PVC pipe using cable ties to ensure an airtight seal between the tracheal rings and the pipe. 1445 
The epiglottis was secured to a piece of balsawood on the bottom of the flow chamber 1446 
using an 18-gauge needle. A 20x20mm white cardboard square was affixed to the 1447 
balsawood in the same plane as the rima glottidis as a reference and in frame of a digital 1448 
camera (HC-V250 high definition digital camera, Panasonic, Osaka, Japan), which was 1449 
mounted above the inlet valve and focused on the rima glottidis.  1450 
Subsequently, the left arytenoid was maximally abducted using the Fiberwire equal to the 1451 
right arytenoid and the flow and inlet valve altered to achieve a target flow rate of 55L/sec 1452 
and a pre-laryngeal pressure (representative of pharyngeal pressure) of 12mmHg. This was 1453 
achieved by adjusting the inlet valve and the voltage regulator to achieve a flow and 1454 
pressure similar to previously reported in vitro and in vivo studies.74,86,94,116,118 The 1455 
Fiberwire was then completely loosened to allow for testing to commence. Each larynx 1456 
was tested under static airflow conditions for a single five second period to obtain data 1457 
during sequential testing as outlined below. Airflow data (flow in L/s and translaryngeal 1458 
differential pressure in mmHg) were recorded for the entire five seconds of testing and the 1459 
middle three seconds averaged for analysis. Translaryngeal impedance was calculated by 1460 




6.3.4 Left to Right Quotient Angle (LRQ) and Cross Sectional Area (CSA)  1464 
A still image was obtained after securing the construct at the desired position and before 1465 
(“before”) the airflow test was initiated. Subsequently, a still image was obtained at 2.5 1466 
seconds into (“during”) each five second test period. These images were used to calculate 1467 
the resultant LRQ and CSA for both before and during each test. The change in LRQ 1468 
(ΔLRQ) and CSA (ΔCSA) was calculated by subtracting the before and during values as a 1469 
means to detect any dynamic airway collapse of the rima glottidis caused by airflow 1470 
testing. The LRQ and CSA was measured and calculated as previously described from 1471 
each photograph by one observer using a soft-ware package (Image J, Bethesda, 1472 
USA).51,110 In short, for LRQ a line was drawn from the ventral to dorsal aspect of the rima 1473 
glottidis and extended by one third to give a point that was used to measure the left (L°) 1474 
and right (R°) arytenoid angles. The LRQ was then calculated by dividing L° from R°. 1475 
Similarly, using Image J the 20x20 mm white square was used to set the scale of the 1476 
program to each photograph and subsequently, the CSA of the rima glottidis was 1477 
determined in mm2. 1478 
 1479 
6.3.5 Phase 1 testing – suture shortening 1480 
For Phase 1 testing, the ends of the suture at the middle of the lateral aspect of the cricoid 1481 
cartilage were attached to the arms of a Vernier Calliper to allow for progressive controlled 1482 
construct shortening at 3mm increments by opening the calliper arms as previously 1483 
reported.119 Airflow testing, as outlined previously, was completed sequentially for each of 1484 
the following steps; 0 mm (suture loop tight and secured but no change in arytenoid 1485 
position from resting) and then successive 3 mm shortening to a maximum of 30 mm of 1486 
shortening (a total of 11 steps per larynx).  1487 
 1488 
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6.3.6 Phase 2 testing – DLPS activation 1489 
Immediately following Phase 1 testing of each larynx, the suture was tied routinely with a 1490 
surgeon’s knot and 4 single throws to fix the left arytenoid at an approximate “before” 1491 
LRQ of 0.5 (i.e. left arytenoid at approximately half of the right sided maximal abduction). 1492 
This starting LRQ was selected based on previous in vitro analysis that demonstrated that 1493 
maximal activation of the DLPS was able to cause an increase in LRQ from 0.7 to 0.97 (an 1494 
effective range of 0.27).119 As a result, if the target LRQ at maximal abduction to 1495 
significantly reduce TLI was to be approximately 0.75 (approximately a CSA of 88%) then 1496 
the starting LRQ was estimated to be approximately 0.48 (i.e. 0.75-0.27=0.48). To allow 1497 
for a margin of error given that this testing involved negative airway pressures and the 1498 
previous in vitro study that generated the LRQ effective range of 0.27 was in resting 1499 
larynges, we selected a starting LRQ for testing of 0.5. 1500 
 Subsequently, the prototype was completed by inserting the DLPS into position between 1501 
the completed suture loop. An inactivated baseline position (approximate LRQ of 0.5) and 1502 
then two levels of activation were achieved by variably injecting saline into the catheter 1503 
port. The level of activation was selected based on previous mechanical testing results; 1504 
inactivated (0psi), moderate activation (25psi) and maximal activation (50psi).115 As 1505 
previously reported, the injection pressure was measured using a pressure syringe (Blue 1506 
DiamondÔ Merit Medical).115 If a pressure of 50psi was not achieved the maximal 1507 
pressure was recorded and the reason for failure to achieve 50psi also recorded.  1508 
 1509 
6.3.7 Statistical Analysis 1510 
Data is reported as mean ± standard error of the mean (SEM). Normality was assessed with 1511 
a Shapiro-Wilk test. Comparison of normally distributed data (impedance before and after 1512 
testing) was made using a paired t-test. Changes in variables of interest (TLI, ΔCSA, 1513 
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ΔLRQ) between baseline and at subsequent degrees of shortening and DLPS activation 1514 
were compared using a repeated-measure analysis of variance (ANOVA). A Tukey post-1515 
hoc test was used when appropriate. Generalised estimating equations (GEE) or simple 1516 
linear regressions were used to model the effect of shortening or DLPS activation on CSA 1517 
and LRQ with (after) or without (before) flow. Significance was defined as p < 0.05. 1518 
 1519 
 1520 
6.4 Results  1521 
All testing was completed and data recorded without complication. The baseline flow and 1522 
pre-laryngeal pressure at maximal bilateral arytenoid abduction (an LRQ of 1.0) prior to 1523 
testing was 56.30 (+/-0.1) L/sec and 11.90 (+/-0.03) mmHg respectively. 1524 
 1525 
6.4.1 Phase 1 testing 1526 
Progressive construct shortening from 0mm (0.60±0.11mmHg/L/sec) to 6mm 1527 
(0.30±0.07mmHg/L/sec) had a significant effect on reducing TLI (p=0.001) (Figure 2).  1528 
Further shortening to 9 mm (0.23±0.05mmHg/L/sec) or more caused additional smaller but 1529 




Figure 2. Change in TLI related to construct shortening in progressive 3 mm steps. Letters 1533 
denote statistical significance.  1534 
 1535 
Similarly, the ΔLRQ was significant (p<0.001) from 0mm (0.25±0.03) to 6mm 1536 
(0.15±0.02) but stopped being significant with further shortening (p>0.05). The ΔCSA was 1537 
significant from 0mm (721.98±57.89mm2) to 15mm (350.88±35.73mm2) but stopped 1538 
being significant with further shortening (p<0.001) (Figure 3). During testing vocal fold 1539 
collapse was note to occur in 3/10 larynges at maximal shortening. At 12mm of suture 1540 
shortening (equivalent to maximal DLPS activation) 6/10 larynges were noted to have 1541 




Figure 3. Representative images of rima glottis demonstrating ΔLRQ and ΔCSA between 1545 
“before” (left) and “during (right) airflow tests for larynx #10 at 0,15,30mm (top, middle 1546 
and bottom images respectively) of shortening. This represents a ΔLRQ and ΔCSA of 0.39 1547 
and 695.56mm2, 0.09 and 382.64mm2, 0 and 137.67mm2, for 0,15 and 30mm of shortening 1548 
respectively.  1549 
 1550 
6.4.2 Phase 2 testing 1551 
Activation of the DLPS prototype caused a significant reduction in TLI from 0 psi 1552 
(0.43±0.08mmHg/L/sec) to 25 psi (0.16±0.04mmHg/L/s)(p<0.001) and a smaller non-1553 
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significant additional reduction in TLI (0.13±0.03mmHg/L/sec)(p>0.05) with maximal 1554 
activation (Figure 4).  1555 
 1556 
 1557 
Figure 4. Change in TLI with DLPS activation. Letters denote differences in TLI of 1558 
statistical significance (p<0.05). 1559 
 1560 
A maximal activation of 31.3±0.96 psi was achieved during testing. Additional activation 1561 
beyond this psi caused balloon prolapse from the DLPS and did not result in further change 1562 
in arytenoid abduction.  Using the results from Phase 1 of the study, maximum activation 1563 
of the DLPS was found to have an effect on TLI reduction equivalent to approximately 12 1564 
mm of suture shortening.  1565 
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There was significant reduction in ΔLRQ (dynamic arytenoid collapse) (Figure 6) at both 1566 
levels of activation of the DLPS (25psi and max psi) compared to baseline (0 psi) (both 1567 
p<0.05) (Figure 5).  1568 
 1569 
 1570 
Figure 5. LRQ both before and during airflow testing with 3 levels of DLPS activation 1571 
during airflow testing. ΔLRQ is the difference between the 2 at each level. Letters denote 1572 
differences of statistical significance (p<0.05). 1573 
 1574 
The ΔCSA was reduced by activation of the DLPS at both levels of activation compared to 1575 
baseline but not significantly so (0, 25 and max psi, all p>0.05) (Figure 6). During testing 1576 




Figure 6. CSA both before and during airflow testing with 3 levels of DLPS activation 1580 
during airflow testing. ΔCSA is the difference between the 2 at each level. Letters denote 1581 
differences of statistical significance (p<0.05). 1582 
 1583 
6.5 Discussion  1584 
The aim of the study presented here was to evaluate the DLPS prototype’s ability to affect 1585 
and maintain a reduction in TLI using a static airflow model. This study followed on from 1586 
previous in vitro evaluations using a mechanical testing system that had found the 1587 
prototype able to produce construct shortening of 7.11 mm whilst under a static 10 N load. 1588 
Additionally, a separate study had found the prototype able to cause increases in LRQ in 1589 
cadaveric larynges equivalent to 18.7 mm of construct shortening.119 Based on the results 1590 
of the study reported here we supported our first hypothesis by finding the DLPS was able 1591 
to achieve a reduction in TLI equivalent to approximately 12 mm of construct shortening. 1592 
We partly supported the second hypothesis in that the DLPS prevented dynamic collapse 1593 
as determined by 25 psi and maximal activation preventing ΔLRQ but were not able to 1594 
prevent ΔCSA during testing. 1595 
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6.5.1 Translaryngeal impedance  1596 
The results from phase 1 of the study found that after 6 mm of construct shortening 1597 
(tightening the suture) there was no additional reduction in the TLI. This is interesting as it 1598 
indicates that relatively little shortening of the laryngoplasty suture construct can result in 1599 
effective reductions in TLI that may be important for clinical success. Previous 1600 
computational fluid mechanic modelling to measure the effects of different degrees of 1601 
arytenoid abduction on upper airway characteristics found that a left arytenoid cartilage 1602 
position resulting in 88% and 75% larynx cross-sectional areas resulted in 4.11 and 5.65% 1603 
reductions in peak airflow.21 Back calculating from our results, 88% and 75% would be 1604 
equal 15-18mm (LRQ 0.7-0.75) and 6mm (LRQ 0.54) respectively (data not shown). Our 1605 
results suggest that at 55L/sec flow, the minimum arytenoid abduction required to 1606 
ameliorate negative effects on TLI would be an LRQ of 0.54 or a CSA of 75%. These 1607 
finding may partially explain the results reported by Barakzai et al in 2009 that found post-1608 
operative performance after LP was not correlated with the degree of arytenoid abduction 1609 
and suggested that horses with a post-operative grade 3 abduction (moderate degree of 1610 
arytenoid abduction, approximately LRQ of 0.5-0.6) can race successfully.111 However, the 1611 
flow rates expected in maximally exercising Thoroughbreds have been reported to range 1612 
from 65-100L/s and it is likely that the degree of shortening required to ameliorate any 1613 
negative effects on TLI at these higher flow rates may be higher than the 6 mm reported in 1614 
our study.8,9,21,38,120,121 The flow rates used in our study are similar to those used in 1615 
previous in vitro studies.74,94,116 Unfortunately, it was not possible to evaluate the effect of 1616 
higher flow rates due to system limitations with regards to effectively measuring flow. 1617 
Further in vitro studies evaluating the effects on TLI at higher flow rates will be required 1618 
to determine what effect this will have on the required degree of arytenoid abduction to 1619 
ameliorate negative effects on TLI.  1620 
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The results of phase 2 of the study demonstrate that the DLPS was able to reduce TLI 1621 
when activated. The reduction in TLI was significant from 0 psi to 25 psi but maximal psi 1622 
caused a smaller (non-significant) additional reduction. This may be due to the maximal 1623 
psi being only 31.3 psi, as the target of 50 psi was not achieved due to the balloon segment 1624 
of the DLPS prolapsing. This indicates that the target psi of 50 psi was too high when used 1625 
in vitro likely because there is minimal resistance to inflation of the balloon in cadaveric 1626 
larynges. In vivo the target activation psi will have to be determined but these in vitro 1627 
findings suggest the maximum benefit of the DLPS prototype will be above 25 psi but 1628 
below 50 psi, likely around 30 – 35 psi. Calculations (data not shown) using the data from 1629 
this study revealed that no activation (0 psi) represented an LRQ of 0.49 and CSA of 66%, 1630 
25 psi activation represented and LRQ of 0.71 and CSA of 0.77% and maximal activation 1631 
represented an LRQ of 0.76 and CSA of 0.82%. When the performance of the DLPS is 1632 
compared to the phase one results of this study and the computational modelling of Rakesh 1633 
et al 2008, the DLPS device was able to achieve increases in LRQ / CSA and resultant 1634 
reductions in TLI that should be useful in vivo.  1635 
 1636 
6.5.2 Dynamic laryngeal collapse 1637 
To evaluate our second hypothesis, we used the ΔLRQ and ΔCSA as a means of evaluating 1638 
for any dynamic collapse produced by initiation of the airflow used in this vacuum system. 1639 
Interestingly, the DLPS was able to prevent significant dynamic arytenoid collapse as 1640 
measured by the ΔLRQ at both 25 psi and maximal psi but not when considered using 1641 
ΔCSA. Review of the dynamic video recordings demonstrated this difference was mostly 1642 
due to vocal fold collapse that influences ΔCSA measurements but not ΔLRQ. In phase 1 1643 
of the study at maximal shortening 3/10 larynges had vocal fold collapse compared to in 1644 
phase 2 at maximal DLPS activation 5/10 larynges had vocal fold collapse. As a result of 1645 
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this difference, we partly supported our second hypothesis depending on which measure of 1646 
dynamic collapse was selected. A similar finding occurred in the phase 1 of this study with 1647 
the ΔCSA being significant for 15 mm and the ΔLRQ for only 6 mm of shortening. 1648 
Review of the images similarly found this was due to vocal fold collapse. Overall, these 1649 
results support the clinical practise of performing a vocal cordectomy or ventriculectomy 1650 
in conjunction with a LP to prevent dynamic collapse of the rima glottis due to vocal fold 1651 
collapse. Similarly, clinical use of the DLPS will also benefit from a concurrent vocal 1652 
cordectomy or ventriculectomy.  1653 
  1654 
6.5.3 Model limitations 1655 
A major limitation of this model is that the airflow target of 55 L/s used, whilst in 1656 
accordance with similar previous in vitro research, represents an airway pressure of horses 1657 
exercising at approximately 100% VO2max.118 However, airflows of up to 100 L/s have 1658 
been recorded in maximally exercising horses.38 Testing using these higher flow rates 1659 
would be useful for further in vitro evaluations with regards to Thoroughbred racehorses. 1660 
However, due to system limitations of only being able to measure a maximum flow of 1661 
60L/s and to allow for comparisons to previous research it was elected to select a target 1662 
flow rate of 55 L/s. 1663 
Further limitations of the model are related to the use of cadaveric larynges, which is 1664 
inherent to in vitro testing. Specifically, there is no muscular function in cadaveric larynges 1665 
that may potentially have an effect on arytenoid abduction and TLI in vivo. The possible 1666 
effect of drying of the larynges during sequential testing influencing the results was 1667 
considered prior to testing. While there is no specific effect of drying known, each test was 1668 
limited to a 5 second period in an effort to ameliorate any effect this may have had. During 1669 
this research, each larynx underwent 14 sequential tests (11 shortening and 3 DLPS levels), 1670 
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which was equal to a total of 70 seconds of active airflow during which no overt evidence 1671 
of drying was noted. This period of airflow was similar to the 60 seconds used by 1672 
Cheetham et al. 2008.86 Finally, during our study the CAD muscle was transacted 1673 
immediately caudal to its insertion on the muscular process. This was performed in an 1674 
effort to minimise any potential effect the cadaveric CAD muscle may have on arytenoid 1675 
position during the testing and ensure a free range of movement of the cricoarytenoideus 1676 
joint. Clinically, surgeons may choose to transect the CAD muscle to improve access to the 1677 
muscular process or to allow access to the cricoarytenoideus joint to facilitate fusion 1678 
procedures.74 For this experiment it was considered that transecting the CAD would 1679 
minimise any potential effect the cadaveric CAD muscle may have between larynges, 1680 
simulate complete laryngeal paralysis and as a result allow for the most accurate 1681 
comparisons to be performed.  1682 
 1683 
In conclusion, the prototype DLPS was able to cause reductions in TLI using a static 1684 
airflow model. This reduction in TLI was approximately equal to 12 mm of suture 1685 
shortening (tightening). The DLPS was able to prevent dynamic arytenoid collapse as 1686 
measured by lack of change in the LRQ but did not prevent dynamic vocal fold collapse, 1687 
resulting in an overall decrease in CSA during dynamic testing. Overall, the DLPS 1688 
prototype evaluated using this in vitro airflow system was shown to be able to achieve and 1689 
maintain arytenoid abduction that was beneficial to airflow. Based on these results further 1690 
evaluation in vivo is supported.  1691 
 1692 
  1693 
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PART IV: IN VIVO PROOF OF CONCEPT STUDY 1694 
  1695 
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Chapter 7: In vivo evaluation of a prototype dynamic laryngoplasty system (DLPS) in 1696 
horses 1697 
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7.1 Abstract 1712 
Objectives- Evaluation of a novel dynamic laryngoplasty system (DLPS) in horses – a 1713 
feasibility study. 1714 
Study Design- In vivo experimental. 1715 
Study units- Adult horses (n=3). 1716 
Methods- Three healthy Standardbred horses had a standing surgical procedure to induce 1717 
complete laryngeal hemiplegia (transection of cricoarytenoideus dorsalis (CAD) tendon of 1718 
insertion), which was subsequently treated using the DLPS. Activation of the DLPS was 1719 
achieved using an injection port exiting through a skin stab (n=2) or using a subcutaneous 1720 
injection port (n=1). Endoscopic examinations of the upper respiratory tract were 1721 
performed pre-, intra- and at 7 days post-operatively. Left to right quotient (LRQ) ratios 1722 
calculated during inactivated and activated states were obtained from still images of the 1723 
rima glottis acquired at 7 days post-operatively. After these images were acquired the 1724 
device was intentionally overinflated to evaluate for device failure. Post-mortem 1725 
examinations were performed on day 7 to evaluate placement of the DLPS and to evaluate 1726 
any complications or failures. 1727 
Results- No complications occurred in the 7-day post-operative period and the DLPS was 1728 
effectively positioned in all 3 horses during a standing procedure. The LRQ at day 7 post-1729 
operatively could be varied from a resting position of 0.73 (+/-0.07) to a maximum of 1.01 1730 
(+/-0.06). At post-mortem, all DLPS components were functional with 2 not between the 1731 
suture loop and the 3rd modified DLPS in the correct location.  1732 
Conclusions- Using the DLPS it was possible to alter the degree of left arytenoid 1733 
abduction post-operatively in 3 adult horses with experimentally induced laryngeal 1734 
hemiplegia. Minor modification of the device to restrain the suture loop within the device 1735 
prevented failure caused by intentional over inflation.  1736 
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Clinical Relevance- The DLPS may provide a useful alternative to traditional LP but 1737 
requires further long term investigation.  1738 
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7.2 Introduction  1739 
The dynamic laryngoplasty system (DLPS) has been developed with the overarching goal 1740 
of being able to alter the degree of arytenoid abduction post-operatively in horses. With 1741 
this goal in mind, the developed prototype has been evaluated in vitro in 3 steps. The first 1742 
step was mechanical testing of the device demonstrating the device could cause functional 1743 
shortening of a suture loop whilst under a static load likely to be seen in vivo.115 The 1744 
second step demonstrated the device was able to cause increased arytenoid abduction when 1745 
activated.119 The final third step using a static airflow model demonstrated the device was 1746 
able to reduce translaryngeal impedance when activated.119 Based on these in vitro findings 1747 
a proof of concept in vivo study was proposed to evaluate DLPS deliverability and 1748 
performance for the short term post-operative period.  1749 
The aims of this study were to 1) evaluate the surgical delivery of a DLPS in standing 1750 
horses, 2) determine the ability of the device to alter arytenoid abduction via an injection 1751 
port at 7 days post-operatively and 3) evaluate the devices’ location at post-mortem 1752 
examination for any errors in delivery or other types of failure. 1753 
We hypothesised that the DLPS 1) would allow for effective controllable alteration in 1754 
arytenoid abduction at 7 days post-operatively, and 2) would not cause significant 1755 
complications associated with its use. We elected to perform the surgery in a standing 1756 
position, as previously reported, to allow for intra-operative assessment of arytenoid 1757 
positioning during DLPS placement.72  1758 
 1759 
7.3 Materials and Methods  1760 
Three adult Standardbred horses aged between 4-10 years old were enrolled in this study, 1761 
which had institutional animal ethics approval (SVS/220/16). All horses’ larynges palpated 1762 
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normally and an endoscopic examination at rest revealed normal laryngeal anatomy and 1763 
function (Havemeyer grade 1 or 2) with no evidence of gross tracheal contamination.  1764 
 1765 
7.3.1 Surgical procedure 1766 
All horses were restrained in stocks, sedated (using detomidine hydrochloride 0.01mg/kg 1767 
IV and butorphanol tartrate 0.01mg/kg IV), and prepared for standing surgery. A video 1768 
endoscope was placed via the right nostril and attached to the rope halter in a position to 1769 
maintain the larynx in view throughout the procedure. Subsequently, an approach to the 1770 
left side of the larynx was performed as previously reported for a standing laryngoplasty 1771 
technique.72 In brief, a 10cm long subcutaneous line of local anaesthetic was injected 1772 
immediately ventral to the left linguofacial vein and an incision made along this line. A 1773 
combination of sharp and blunt dissection ventral to the vein was performed to allow 1774 
access to the left dorsolateral aspect of the larynx. At this point the tendon of insertion of 1775 
the left cricoarytenoideus (CAD) muscle was isolated and transected to induce complete 1776 
left laryngeal dysfunction, which was confirmed using the video endoscope.  The DLPS 1777 
was then placed as follows: Using a trocar point half circle needle, #2 Fiberwire (Arthrex) 1778 
suture was passed through the cricoid cartilage approximately 1.5cm lateral to the midline 1779 
and 1.5cm from the caudal edge. For the arytenoid attachment a FASTak®II (AR-1324HF, 1780 
Arthrex) suture anchor was placed in the muscular process of the arytenoid cartilage, 1781 
10mm cranial to the insertion of the CAD muscle as described previously (Figure 1A).113 1782 
The balloon element of the DLPS was then placed in position between the resultant suture 1783 
loop (Figure 1B). At surgery, the left arytenoid was placed at an estimated left to right 1784 
quotient (LRQ) angle of 0.7 when the DLPS was in an inactivated state. In the first two 1785 
horses the attached catheter was exited through a stab skin incision at the caudal aspect of 1786 
the incision prior to routine closure in layers. For the final horse the DLPS was modified to 1787 
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prevent suture prolapse (a PEEK pillar perpendicular to the suture direction connecting the 1788 
PEEK discs) and the catheter was tunnelled subcutaneously (Figure 1C) and connected to 1789 
an injection port (Vital-Portâ titanium vascular access system, IP-S7110, Cook Medical) 1790 
(Figures 1D and 1E) that was placed in a subcutaneous pocket via a 3cm skin incision on 1791 
the neck (Figure 1F). The catheters and the subcutaneous injection port were used to 1792 
activate the DLPS by injection of saline into the exposed port or via a needle inserted 1793 
transcutaneously.  1794 
 1795 
 1796 
Figure 1. Intra-operative images of horse 3 demonstrating, A) arytenoid anchor placement, 1797 
B) DLPS (with added pillar) being placed, C) catheter tunnelled subcutaneously, D) 1798 
injection port being tested, E) subcutaneous injection port being placed and F) final post-1799 
operative appearance.   1800 
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7.3.2 Post-operative care / examinations  1802 
All horses received procaine penicillin (22,000IU/kg) intramuscularly twice a day, 1803 
gentamicin (8.8mg/kg) intravenously once a day and phenylbutazone (2.2mg/kg) orally 1804 
once a day for 5 days post-operatively. Horses were fed from the ground in a hospital box 1805 
for the duration of the study. At the completion of the study (7 days post-operatively) the 1806 
horses were restrained in stocks and an endoscopic examination of the larynx and trachea 1807 
performed via the right nostril.  Any gross evidence of tracheal contamination was noted. 1808 
Whilst observing the larynx endoscopically, the DLPS was activated by injection of saline 1809 
(range 3-4ml) to assess the range of arytenoid abduction attainable and during maximal 1810 
right arytenoid abduction. Once this was performed several times the DLPS was 1811 
intentionally overinflated with 6 mls of saline. For the first two horses this activation was 1812 
performed via the injection port exiting the surgical incision or in the final horse via the 1813 
subcutaneous injection port using a needle inserted transcutaneously. Digital recordings 1814 
were made of the endoscopic examinations at 7-days post-operatively and still images 1815 
obtained pre-and post-inflation at points of maximal right arytenoid abduction. 1816 
Subsequently, all horses were euthanized and the surgical site dissected to evaluate for any 1817 
errors in device placement (i.e. if not located between the suture loop) or other types of 1818 
failure (e.g. anchor movement, balloon rupture, prolapse or other construct failure). 1819 
 1820 
7.3.3 Left to Right Quotient angle ratio (LRQ) 1821 
Arytenoid LRQ was measured and calculated as previously described from each still image 1822 
by an experienced observer (B.A.) using Image J.51,110 In short, using a digital image, 1823 
acquired during maximal stimulated right arytenoid abduction, a line was drawn from the 1824 
ventral to the dorsal aspect of the rima glottidis and then extended by one third to give a 1825 
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point that was used to measure the left (LO) and right (RO) arytenoid angles. The LRQ was 1826 
then calculated from dividing LO from RO.  1827 
 1828 
All data reported as mean +/- SD throughout unless otherwise stated.  1829 
 1830 
7.4 Results 1831 
All surgical procedures were completed without complications, were of less than 45 1832 
minutes’ duration and did not require additional doses of sedation. The DLPS device was 1833 
readily positioned without complication.  1834 
Post-operatively all horses were clinically normal with no evidence of excessive pain or 1835 
swelling of the surgical site and maintained a normal appetite for the duration of the study. 1836 
During the post-operative period, no coughing or nasal discharge noted. Routine wound 1837 
management was required for the 2 cases with catheters exiting the skin, with mild serous 1838 
drainage being cleaned daily. The subcutaneous portal was visible and easily palpated. 1839 
Injection into the portal was easily performed with routine restraint. The LRQ at day 7 1840 
post-operatively could be varied from a resting position of 0.73 (+/-0.07) to a maximum of 1841 
1.01 (+/-0.06) (Figure 2 and 3).  1842 
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 1843 
Figure 2. LRQ (mean +/- SD) at 7 days post-operatively pre-and post-inflation of the 1844 
DLPS.  1845 
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 1846 
Figure 3. Endoscopic images of the three horses (top to bottom) at day 7 post-operatively 1847 
pre (left) and post (right) inflation of the DLPS in each horse respectively. 1848 
  1849 
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Intentional over inflation of the balloon using 6 mls of saline caused a sudden loss of 1850 
abduction in the first two horses. This loss of abduction did not occur in the third horse and 1851 
in this horse additional injections of saline caused no apparent effect on the observed 1852 
maximal arytenoid abduction. When the saline was removed in the third horse after over 1853 
inflation, the arytenoid returned to the resting position. Endoscopic examinations of the 1854 
trachea revealed no gross evidence of food aspiration in any case. 1855 
At post-mortem, for the first two horses, the device was displaced from the suture loop and 1856 
sitting immediately adjacent and dorsal to the suture loop. The balloons were intact and the 1857 
DLPS unit functional but out of position. For the third horse the DLPS was in place and 1858 
activation of the device caused changes in arytenoid abduction as expected. Overall, the 1859 
remainder of the construct (suture loop and anchor) were in place without evidence of 1860 
failure in all three horses. There was a smooth lined tissue space at the surgical site with a 1861 
small amount of serous fluid.  1862 
 1863 
7.5 Discussion  1864 
We aimed to evaluate the feasibility of delivering a prototype DLPS in standing horses that 1865 
was able to selectively alter arytenoid abduction at 7 days post-operatively. Based on the 1866 
results from this limited number of horses we achieved “proof of concept” that post-1867 
operative selective alteration of arytenoid abduction was feasible using a prototype DLPS. 1868 
Specifically, we supported our first hypotheses in that the DLPS allowed for effective 1869 
controllable alteration in arytenoid abduction at 7 days post-operatively. Regarding our 1870 
second hypothesis, no post-operative complications were identified in any of the three 1871 
horses over the 7 days of the study. However, over inflation of the device in the first two 1872 
horses led to displacement of the suture, leading to a failure to abduct the arytenoid 1873 
cartilage on subsequent attempts. A post-mortem examination found the DLPS were not in 1874 
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the correct position between the suture loop (displaced), which prompted a minor device 1875 
modification for the third horse to prevent this displacement occurring. As a result of this 1876 
modification and despite intentional over-inflation the 3rd device was in correct position 1877 
and able to cause changes in arytenoid abduction. The balloon and PEEK components 1878 
remained intact in all three cases. 1879 
 1880 
This was a pilot study and clearly has the limitations of only a small number of horses and 1881 
only a short survival period. This study suggests that the device is well tolerated and 1882 
allows for variable adjustment of arytenoid positioning in the short term. Longer term 1883 
evaluation of the device should investigate the effects of potential peri-prosthesis fibrosis 1884 
or long term failure due to repetitive loading.  1885 
 1886 
From a mechanical point of view, recent in vitro evaluation using limited cyclical and 1887 
ramp to failure testing suggests that the balloon element of the device should be able to 1888 
withstand at least preliminary in vivo loading.115 The remaining element of the DLPS is 1889 
made from polyetheretherketone (PEEK) which is commonly used in medical devices as it 1890 
is safe, easily manufactured and impervious to moisture and degradation.122 Finally, the 1891 
catheter and injection port (used in horse three) is a subcutaneous portal system already 1892 
used routinely in human medicine.123 As a result, it is expected that these components will 1893 
be very robust. The balloon component, whilst used in medical settings in an indwelling 1894 
location, is the relative point of weakness in the DLPS prototype due to the cyclical 1895 
functionality required. This component will warrant evaluation regarding longer term in 1896 
vivo performance as it has not been used previously in a similar setting that we are aware 1897 
of. At post-mortem, the DLPS in the first two horses had been displaced from between the 1898 
suture loops by intentional over inflation of the balloon. This was done in an effort to 1899 
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determine if the balloon would rupture or how the device would fail. For the third horse the 1900 
PEEK element of the DLPS had a pillar of PEEK added at both peripheries of the device at 1901 
180o to each other and perpendicular to the suture loop, to prevent the suture from 1902 
displacing from within the confines of the device. At post-mortem, this device was still in 1903 
location and functioning.  This minor modification to prevent accidental over inflation 1904 
should be used in all future similar devices.  1905 
How the DLPS will perform in an exercising pressurised larynx is also unknown at this 1906 
time. Previous in vitro testing found the construct to be very stiff and 9 out of 10 constructs 1907 
did not fail during ramp loading to 100N.115 Furthermore, an in vitro evaluation of the 1908 
DLPS using a static airflow model showed the DLPS could achieve an increase in and 1909 
maintain arytenoid abduction that resulted in a significant reduction in translaryngeal 1910 
impedance during airflows of 55L/second.124 As a result of the previous in vitro 1911 
evaluations and this in vivo proof of concept pilot the DLPS warrants further longer term 1912 
evaluation likely using an exercising model.  1913 
Delivery of the DLPS in vivo during a standing procedure was readily achieved in this pilot 1914 
study. Surgical familiarity with the DLPS and technique is essential prior to attempting 1915 
effective delivery and will be directly related to surgical outcome. Standing surgical 1916 
delivery was considered to be desirable to allow for the most accurate selection of the 1917 
desired degree of arytenoid abduction during normal respiration. However, the DLPS 1918 
could be used under general anaesthesia if desired and the authors have performed the 1919 
procedure using cadaveric horses in lateral position as for a more traditional laryngoplasty 1920 
performed under general anaesthesia.   1921 
 1922 
There are a number of potential uses for the device including correction of disappointing 1923 
post-operative abduction, or to correct more gradual post-operative abduction loss. 1924 
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Secondly, the device might be used to selectively increase the degree of arytenoid 1925 
abduction during periods of exercise and improve the athletic performance of the horse as 1926 
a result. Finally, the device might also be used for research applications related to the 1927 
effects of differing degrees of arytenoid abduction on airflow and lower airway 1928 
contamination, using each horse as its own control. 1929 
The clinical significance of being able to alter the degree of arytenoid abduction post-1930 
operatively with regards to the incidence of longer-term complications and general 1931 
performance are unknown. However, the results of this research achieved our aim of 1932 
delivering the DLPS in sedated standing horses and allowed for effective alteration in the 1933 
degree of arytenoid abduction at 7 days post-operatively. Based on the results of this study 1934 
further longer term evaluation of the DLPS and exercise studies are warranted.  1935 
  1936 
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PART V: CONCLUSION	  1937 
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Chapter 8: General Discussion 1938 
At the outset of this thesis we set out to develop a laryngoplasty technique that was 1939 
fundamentally different to the traditional laryngoplasty in that it could be altered post-1940 
operatively. We theorised this may be useful to equine surgeons to allow for increased 1941 
arytenoid abduction as a minimum and additionally might allow for a dynamic or variable 1942 
laryngoplasty construct that could be used to “select” the optimal degree of arytenoid 1943 
abduction for an individual horse.  1944 
We were successful in developing a DLPS that was able to produce and maintain a 1945 
variable degree of arytenoid abduction in the face of representative airflows in vitro. 1946 
Furthermore, we validated the prototype during a proof of concept in vivo study and found 1947 
the DLPS allowed for controlled variation of the arytenoid position at 7 days post-1948 
operatively. This is the first reported laryngoplasty device that can readily and effectively 1949 
cause alteration in the degree of arytenoid abduction post-operatively. This prototype or 1950 
one of similar concept might be clinically useful to improve the success rate for horses 1951 
treated for dynamic laryngeal collapse caused by RLN. Numerous different prototypes 1952 
were conceived and subsequently discarded due to a variety of reasons prior to 1953 
development of the final prototype DLPS that was used for in vitro and in vivo testing. 1954 
During the final stages of the in vivo testing, a small modification of the device was made 1955 
to prevent accidental over inflation. It is possible that with further in vivo study, such as 1956 
using an exercising model, further modifications may need to be made in an effort to 1957 
improve the functionality of the device.  1958 
The portion of the device that is the weak point is the balloon component. There are a 1959 
variety of materials that the balloon can be made from and if this element of the device is a 1960 
problem in future research than it will have to be revised. That being said, the remainder of 1961 
the prototype is extremely robust and unlikely to fail in vivo. As a result of the robustness 1962 
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of the device when inactivated (no balloon element functioning), the inactivated position 1963 
selected at surgery should be at the lowest end of what is considered to be the minimal 1964 
degree of arytenoid abduction. Based on the above research this would represent a target of 1965 
slightly over a resting LRQ of 0.5 or a CSA of 0.75%, which equates to approximately 1966 
6mm of effective construct shortening. This degree of arytenoid abduction ameliorated the 1967 
negative effects on TLI using an in vitro static airflow model with flow rates of 55L/min, 1968 
similar to those that would occur at approximately 100% VO2max.118 Horses maximally 1969 
exercising will generate flow rates significantly higher than this (reported up to 100L/sec) 1970 
and they will likely benefit from a higher degree of arytenoid abduction that will be 1971 
possible using the DLPS post-operatively.8,120,121 This should result in maximisation of 1972 
airway function by specifically allowing it to be tailored to an individual horse.  1973 
The effectiveness of the developed DLPS to return airflow mechanics and exercise 1974 
capacity to normal whilst reducing complications such as tracheal contamination is 1975 
currently unknown. Future work will include evaluating the DLPS using an exercising 1976 
model similar to the one used by Radcliffe et al. (2006) that compared horses in 3 phases. 1977 
These phases were; normal laryngeal function, induced laryngeal hemiplegia and after 1978 
treatment with laryngoplasty or arytenoidectomy. We intend to evaluate the prototype 1979 
using horses completing an exercise test on a high-speed treadmill at or as close as possible 1980 
to racing speeds and conditions.  The horses will undergo testing at; 1) normal laryngeal 1981 
function, 2) induced laryngeal dysfunction and then using 2 arms, after treatment using 1982 
either a traditional laryngoplasty or a DLPS. Similar to the Radcliffe et al. (2006) study the 1983 
rate of complications and ability to return horses with laryngeal collapse to normal will be 1984 
evaluated. After this exercising evaluation and over a longer term, the horses will be 1985 
monitored intermittently to evaluate for any effect on functionality caused by potential 1986 
fibrosis.  1987 
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 In conclusion, we developed a prototype DLPS and evaluated it thoroughly in vitro prior 1988 
to demonstrating the proof of concept of the device in vivo. We demonstrated the effective 1989 
surgical deliverability of the DLPS in horses using a standing sedated approach. Using the 1990 
DLPS device the degree of arytenoid abduction could be effectively altered post-1991 
operatively which may be useful to equine surgeons in the future.    1992 
	 126	
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